<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6730933</article-id><article-id pub-id-type="pmid">31449532</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0007622</article-id><article-id pub-id-type="publisher-id">PNTD-D-19-00307</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Guillain-Barre syndrome</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Guillain-Barre syndrome</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Guillain-Barre syndrome</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Brazil</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Zika Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Arboviral Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Colombia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Caribbean</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Neglected Tropical Diseases</subject><subj-group><subject>Chikungunya Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Chikungunya Infection</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Incidence of Guillain-Barr&#x000e9; Syndrome (GBS) in Latin America and the Caribbean before and during the 2015&#x02013;2016 Zika virus epidemic: A systematic review and meta-analysis</article-title><alt-title alt-title-type="running-head">Incidence of Guillain-Barr&#x000e9; Syndrome in LAC and arboviral disease outbreaks</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Capasso</surname><given-names>Ariadna</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ompad</surname><given-names>Danielle C.</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vieira</surname><given-names>Dorice L.</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wilder-Smith</surname><given-names>Annelies</given-names></name><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8997-8897</contrib-id><name><surname>Tozan</surname><given-names>Yesim</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>NYU College of Global Public Health, New York University, New York, New York, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>New York University Health Sciences Library, NYU School of Medicine, NYU Langone Medical Center, New York, New York, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Global Health and Epidemiology, University of Umea, Umea, Sweden</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Harley</surname><given-names>David</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Queensland, AUSTRALIA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>tozan@nyu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2019</year></pub-date><volume>13</volume><issue>8</issue><elocation-id>e0007622</elocation-id><history><date date-type="received"><day>4</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Capasso et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Capasso et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0007622.pdf"/><abstract><sec id="sec001"><title>Background</title><p>A severe neurological disorder, Guillain-Barr&#x000e9; syndrome (GBS) is the leading cause of acute flaccid paralysis. Enhanced surveillance of GBS in Latin America and the Caribbean (LAC) following the 2015&#x02013;2016 Zika virus (ZIKV) epidemic presents an opportunity to estimate, for the first time, the regional incidence of GBS.</p></sec><sec id="sec002"><title>Methods and findings</title><p>For this systematic review and meta-analysis, we searched nine scientific databases and grey literature from January 1, 1980 to October 1, 2018. Sources with primary data on incident GBS cases in LAC within a well-defined population and timeframe, published in English, Spanish, Portuguese, or French, were included. We calculated the annual GBS incidence rates (IRs) and 95% confidence intervals (CIs) for each source based on published data. Following an assessment of heterogeneity, we used random-effects meta-analysis to calculate the pooled annual IR of GBS. The study is registered with PROSPERO, number CRD42018086659. Of the 6568 initial citation hits, 31 were eligible for inclusion. Background annual GBS IRs in Latin America ranged from 0.40 in Brazil to 2.12/100,000 in Chile. The pooled annual IR in the Caribbean was 1.64 (95% CI 1.29&#x02013;2.12, <italic>I</italic><sup><italic>2</italic></sup>&#x0003c;0.01, p = 0.44). During the ZIKV epidemic, GBS IRs ranged from 0.62 in Mexico to 9.35/100,000 in Martinique. GBS increased 2.6 (95% CI 2.3&#x02013;2.9) times during ZIKV and 1.9 (95% CI 1.1&#x02013;3.4) times during chikungunya outbreaks over background rates. A limitation of this review is that the studies included employed different methodologies to find and ascertain cases of GBS, which could contribute to IR heterogeneity. In addition, it is important to consider that data on GBS are lacking for many countries in the region.</p></sec><sec id="sec003"><title>Conclusions</title><p>Background IRs of GBS appear to peak during arboviral disease outbreaks. The current review contributes to an understanding of the epidemiology of GBS in the LAC region, which can inform healthcare system planning and preparedness, particularly during arboviral epidemics.</p></sec><sec id="sec004"><title>Trial registration</title><p>Registered with PROSPERO: <ext-link ext-link-type="uri" xlink:href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3320145">CRD42018086659</ext-link>.</p></sec></abstract><abstract abstract-type="summary"><title>Author summary</title><p>A severe neurological disorder, Guillain-Barr&#x000e9; syndrome (GBS) is the leading cause of acute flaccid paralysis. This is the first systematic review on GBS incidence in Latin America and the Caribbean before and during arboviral disease outbreaks. There is a large sub-regional and annual fluctuation in the incidence of GBS. Background annual GBS incidence rates (IRs) in Latin America ranged from 0.40 in Brazil to 2.12/100,000 in Chile. The pooled annual IR in the Caribbean was 1.64 (95% CI 1.29&#x02013;2.12, <italic>I</italic><sup><italic>2</italic></sup>&#x0003c;0.01, p = 0.44). During the ZIKV epidemic, GBS IRs ranged from 0.62 in Mexico to 9.35/100,000 in Martinique. GBS increased 2.6 times during ZIKV and 1.9 times during chikungunya outbreaks over background rates. GBS is a costly disease, which can result in long-term disability and high mortality rates in resource constrained healthcare settings. Because GBS can be triggered by arboviral infections, baseline incidence of GBS is critical for detecting neglected tropical disease outbreaks. The current review contributes to an understanding of the epidemiology of GBS in the LAC region, which can inform healthcare system planning and preparedness.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100010686</institution-id><institution>H2020 European Institute of Innovation and Technology</institution></institution-wrap></funding-source><award-id>734584</award-id><principal-award-recipient><name><surname>Wilder-Smith</surname><given-names>Annelies</given-names></name></principal-award-recipient></award-group><funding-statement>AWS's participation in this study was partially funded by the European Union's Horizon 2020 research and innovation program ZikaPLAN, under Grant Agreement No. 734584. URL:<ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/programmes/horizon2020/en">https://ec.europa.eu/programmes/horizon2020/en</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="2"/><page-count count="19"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2019-09-06</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>A rare but severe autoimmune neuropathy, Guillain-Barr&#x000e9; syndrome (GBS) is the most common type of acute flaccid paralysis (AFP) [<xref rid="pntd.0007622.ref001" ref-type="bibr">1</xref>]. Often preceded by infections such as <italic>Campylobacter jejuni</italic>, about 25% of patients require mechanical ventilation [<xref rid="pntd.0007622.ref002" ref-type="bibr">2</xref>]. Prognosis varies greatly based on GBS type and urgent care availability [<xref rid="pntd.0007622.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pntd.0007622.ref005" ref-type="bibr">5</xref>]. Many patients report residual deficits, including pain, limited mobility, and fatigue, years after disease onset [<xref rid="pntd.0007622.ref004" ref-type="bibr">4</xref>, <xref rid="pntd.0007622.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pntd.0007622.ref008" ref-type="bibr">8</xref>]. Mortality rates range from 3&#x02212;7% [<xref rid="pntd.0007622.ref003" ref-type="bibr">3</xref>, <xref rid="pntd.0007622.ref009" ref-type="bibr">9</xref>], although they can be higher in settings with limited access to intensive care [<xref rid="pntd.0007622.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0007622.ref011" ref-type="bibr">11</xref>]. In 2008, the total annual cost of GBS in the U.S. alone was estimated at $1.7 billion (95% CI $1.6 to 1.9 billion) [<xref rid="pntd.0007622.ref012" ref-type="bibr">12</xref>].</p><p>The median global incidence rate (IR) of GBS was estimated at 1.10 per 100,000 person-years (range, 0.81&#x02013;1.89) [<xref rid="pntd.0007622.ref013" ref-type="bibr">13</xref>]. However, this estimate was based on data from studies conducted in Europe and North America [<xref rid="pntd.0007622.ref013" ref-type="bibr">13</xref>]. Worldwide, there are large variations in the incidence of GBS, ranging from 0.38 (95% CI 0.25&#x02013;0.56) to 2.53 (95% CI 1.87&#x02013;3.56) per 100,000, with most studies reporting annual IRs between 1.1 and 1.8 per 100,000 [<xref rid="pntd.0007622.ref014" ref-type="bibr">14</xref>]. Prior to the 2015&#x02013;2016 Zika virus (ZIKV) epidemic in Latin America and the Caribbean (LAC), there were few published studies on the incidence of GBS in the region, with an exception among children. As part of polio eradication efforts, AFP in children under 15 years of age has been a notifiable event in all LAC countries since the 1980s [<xref rid="pntd.0007622.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pntd.0007622.ref017" ref-type="bibr">17</xref>]. Using polio eradication surveillance data, in 2010, Landaverde et al. estimated 0.82 cases of GBS per 100,000 among children under 15 years of age (range, 0.72&#x02013;0.90) [<xref rid="pntd.0007622.ref018" ref-type="bibr">18</xref>].</p><p>ZIKV is an enveloped positive-strand RNA member of the <italic>Flavivirus</italic> genus in the Flaviviridae family. Other flaviviruses include dengue, yellow fever, West Nile virus and Japanese encephalitis virus, many of which are associated with neurological disease. Like these viruses, ZIKV is principally transmitted by a mosquito bite and is thus described as an arthropod-borne virus or &#x02018;arbovirus&#x02019;. Its primary vector is the <italic>Aedes aegypti</italic> mosquito, which transmits the virus between humans and is widespread in tropical regions [<xref rid="pntd.0007622.ref019" ref-type="bibr">19</xref>].</p><p>ZIKV is known to be neurotropic; infection halts proliferation of neural progenitor cells and may induce cell death, leading to ZIKV-related microcephaly [<xref rid="pntd.0007622.ref020" ref-type="bibr">20</xref>]. Beyond congenital Zika syndrome, direct viral invasion as well as a parainfective or postinfective autoimmune response may contribute to GBS pathogenesis [<xref rid="pntd.0007622.ref021" ref-type="bibr">21</xref>, <xref rid="pntd.0007622.ref022" ref-type="bibr">22</xref>]. An association between GBS and ZIKV was first established in a case-control study in French Polynesia [<xref rid="pntd.0007622.ref023" ref-type="bibr">23</xref>]. During the 2015&#x02013;2016 ZIKV epidemic, many countries in LAC reported increases in GBS cases, particularly in the beginning of 2016 [<xref rid="pntd.0007622.ref024" ref-type="bibr">24</xref>, <xref rid="pntd.0007622.ref025" ref-type="bibr">25</xref>]. In 2016, the World Health Organization (WHO) concluded that ZIKV infection was a plausible trigger for GBS [<xref rid="pntd.0007622.ref026" ref-type="bibr">26</xref>]. The chikungunya (CHIKV) [<xref rid="pntd.0007622.ref027" ref-type="bibr">27</xref>, <xref rid="pntd.0007622.ref028" ref-type="bibr">28</xref>] and dengue (DENV) viruses [<xref rid="pntd.0007622.ref029" ref-type="bibr">29</xref>], two other arboviruses that are endemic in parts of the LAC region, have also been investigated as possible GBS antecedent infectious agents.</p><p>Enhanced GBS surveillance [<xref rid="pntd.0007622.ref030" ref-type="bibr">30</xref>] and increased research present a unique opportunity to assess the background IR of GBS in the LAC region in the aftermath of recent arboviral epidemics. This review aims to assess the background population-wide incidence of GBS in Latin America and the Caribbean through a synthesis of observational studies. For the purposes of this study, &#x0201c;background incidence&#x0201d; refers to the rates reported during time periods with no arboviral epidemic. To our knowledge this is the first systematic review on GBS in this region. A secondary aim of this review is to ascertain the incidence of GBS during arboviral disease outbreaks.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Methods</title><sec id="sec007"><title>Search strategy and selection criteria</title><p>Our protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocols (PRISMA-P) guidelines and the Meta-analyses of Observational Studies in Epidemiology (MOOSE) Checklist (see <xref ref-type="supplementary-material" rid="pntd.0007622.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pntd.0007622.s002">S2</xref> Files) [<xref rid="pntd.0007622.ref031" ref-type="bibr">31</xref>]. We developed the search word criteria by reviewing PubMed MeSH and Embase Emtree subject headings and keywords. We searched nine electronic databases. Our full search terms are provided in the appendix. We conducted a grey literature search on OpenGrey and OAIster and hand-searched relevant journals and the bulletins of ministries of health cited in bibliographic references of the articles selected for full-text review (see <xref ref-type="supplementary-material" rid="pntd.0007622.s003">S3 File</xref>). We also reviewed the references of all included articles. Inclusion criteria were peer-reviewed and government publications that presented primary data on incident GBS cases in LAC within a well-defined population and timeframe and that were published in English, Spanish, Portuguese, or French between January 1, 1980 to October 1, 2018. The search timeframe was decided upon to update the worldwide review by McGrogan [<xref rid="pntd.0007622.ref014" ref-type="bibr">14</xref>] from 1980 to 2008. Review papers were excluded. After removing duplicates, two authors (AC, DLV) independently screened articles by title and abstract based on the inclusion criteria and agreed on those for full-text review. A standard extraction form was developed and tested for reliability. Disagreements were resolved by these two reviewers.</p></sec><sec id="sec008"><title>Data analysis</title><p>One author (AC) extracted the following items from the included articles onto the extraction form: study design, country, region, data collection year(s), population size, age, sex, GBS type, GBS diagnostic criteria, incident cases, statistical measures, and circulating arboviral diseases (ZIKV, DENV, or CHIKV). Three other authors (DLV, DCO, YT) extracted data from 30% of the records for quality control.</p><p>All data were standardized to annual mean IR by dividing the number of GBS cases reported by the number of weeks of data capture and multiplying the result by 52 weeks. The result was entered as annual GBS cases into the software program, and together with the base population, was used to calculate the annual IR per 100,000 persons. When necessary, we attempted to contact the authors to obtain clarifying information. Three authors (AC, DCO, YT) assessed studies for risk of bias using a tool developed for prevalence studies [<xref rid="pntd.0007622.ref032" ref-type="bibr">32</xref>]. To reduce publication bias [<xref rid="pntd.0007622.ref033" ref-type="bibr">33</xref>], we searched the grey literature, institutional websites, and conference abstracts. The study protocol was registered with PROSPERO (CRD42018086659, available at <ext-link ext-link-type="uri" xlink:href="https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=86659">https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=86659</ext-link>).</p><p>We performed the meta-analysis using the <italic>metaprop</italic> command in Stata version 15 (College Station, Texas, USA). Annualized GBS cases and population sizes were entered for every selected study. Given high heterogeneity, we performed sub-group analyses by: geography (Latin America versus the Caribbean; Southern Cone, Central and North America, and the Caribbean); time (before and during an epidemic outbreak); population (all and under 15 years of age); and case ascertainment (administrative data using ICD codes only and medical record review). Double arcsine transformation and random-effects models were used to calculate pooled IR estimates of GBS [<xref rid="pntd.0007622.ref034" ref-type="bibr">34</xref>].</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><p>The database search identified 6568 citations. An additional 18 citations were identified through hand searching. After removing duplicates, 4148 citations were screened based on title and abstract. Of these, 4013 did not meet inclusion criteria. We reviewed 135 full-text articles, of which 31 were eligible for inclusion (<xref ref-type="fig" rid="pntd.0007622.g001">Fig 1</xref>). Of the 31 studies, 28 reported country-specific GBS rates from 13 LAC countries (Tables <xref rid="pntd.0007622.t001" ref-type="table">1</xref> &#x00026; <xref rid="pntd.0007622.t002" ref-type="table">2</xref>), 3 regional rates,[<xref rid="pntd.0007622.ref018" ref-type="bibr">18</xref>, <xref rid="pntd.0007622.ref035" ref-type="bibr">35</xref>, <xref rid="pntd.0007622.ref036" ref-type="bibr">36</xref>] 15 background rates [<xref rid="pntd.0007622.ref018" ref-type="bibr">18</xref>, <xref rid="pntd.0007622.ref035" ref-type="bibr">35</xref>&#x02013;<xref rid="pntd.0007622.ref048" ref-type="bibr">48</xref>], 11 rates during an arboviral outbreak [<xref rid="pntd.0007622.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pntd.0007622.ref059" ref-type="bibr">59</xref>], and 5 compared rates before and during an outbreak [<xref rid="pntd.0007622.ref027" ref-type="bibr">27</xref>, <xref rid="pntd.0007622.ref060" ref-type="bibr">60</xref>&#x02013;<xref rid="pntd.0007622.ref063" ref-type="bibr">63</xref>]. Many studies presented data from Brazil (29%) and Colombia (16%), and the majority (68%) were published in 2015 or later. Of the studies that assessed background IRs, the mean number of years studied was 7.2 (range, 1&#x02013;13.6 years).</p><fig id="pntd.0007622.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007622.g001</object-id><label>Fig 1</label><caption><title>PRISMA flow chart for a systematic review and meta-analysis of Guillain-Barr&#x000e9; Syndrome (GBS) in Latin America and the Caribbean before and during the 2015&#x02013;2016 Zika virus epidemic.</title></caption><graphic xlink:href="pntd.0007622.g001"/></fig><table-wrap id="pntd.0007622.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007622.t001</object-id><label>Table 1</label><caption><title>Characteristics of the 31 included studies of incidence of Guillain-Barr&#x000e9; Syndrome, by location and study period.</title></caption><alternatives><graphic id="pntd.0007622.t001g" xlink:href="pntd.0007622.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Author/s (Year)</th><th align="left" rowspan="1" colspan="1">Country</th><th align="left" rowspan="1" colspan="1">Location</th><th align="left" rowspan="1" colspan="1">Study Period<xref ref-type="table-fn" rid="t001fn001"><sup>1</sup></xref></th><th align="left" rowspan="1" colspan="1">Case ascertainment</th><th align="left" rowspan="1" colspan="1">Case definition</th><th align="left" rowspan="1" colspan="1">Ages</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Central America and Mexico</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Molinero et al (2003)</td><td align="left" rowspan="1" colspan="1">Honduras</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">1989&#x02013;1999</td><td align="left" rowspan="1" colspan="1">Prospective hospital-based study of acute flaccid paralysis (AFP) cases</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">&#x0003c;15</td></tr><tr><td align="left" rowspan="1" colspan="1">de la Pe&#x000f1;a et al (2015)</td><td align="left" rowspan="1" colspan="1">Mexico</td><td align="left" rowspan="1" colspan="1">Jalisco (state)</td><td align="left" rowspan="1" colspan="1">2005&#x02013;2009</td><td align="left" rowspan="1" colspan="1">Retrospective hospital-based review of medical discharge records</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">&#x02265;18</td></tr><tr><td align="left" rowspan="1" colspan="1">del Carpio Orantes et al (2018)</td><td align="left" rowspan="1" colspan="1">Mexico</td><td align="left" rowspan="1" colspan="1">North Veracruz (delegation)</td><td align="left" rowspan="1" colspan="1">2016&#x02013;2017</td><td align="left" rowspan="1" colspan="1">Retrospective hospital-based review of medical discharge records</td><td align="left" rowspan="1" colspan="1">Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>South America</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Rojas et al (2009)</td><td align="left" rowspan="1" colspan="1">Argentina</td><td align="left" rowspan="1" colspan="1">Buenos Aires (city)</td><td align="left" rowspan="1" colspan="1">1999&#x02013;2007</td><td align="left" rowspan="1" colspan="1">Retrospective hospital-based review of medical records</td><td align="left" rowspan="1" colspan="1">ICD-9 357.0 &#x00026; NINCDS</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Codeb&#x000f3; et al (2016)</td><td align="left" rowspan="1" colspan="1">Argentina</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2007&#x02013;2013</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records in national database</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Dias-Tosta et al (2002)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">1990&#x02013;1996</td><td align="left" rowspan="1" colspan="1">National AFP surveillance system and medical diagnosis</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">&#x0003c;15</td></tr><tr><td align="left" rowspan="1" colspan="1">Dourado et al (2012)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Rio Grande do Norte (state)</td><td align="left" rowspan="1" colspan="1">1994&#x02013;2007</td><td align="left" rowspan="1" colspan="1">Prospective hospital-based series</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Rocha et al (2004)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Sao Paulo (city)</td><td align="left" rowspan="1" colspan="1">1995&#x02013;2002</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Barcellos et al (2017)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Northeast region</td><td align="left" rowspan="1" colspan="1">January 2008-May 2015 June-October 2015</td><td align="left" rowspan="1" colspan="1">Admission records in national hospital information system</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Souza (2018)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Piau&#x000ed; (state)</td><td align="left" rowspan="1" colspan="1">2014&#x02013;2016</td><td align="left" rowspan="1" colspan="1">Active hospital-based state surveillance system</td><td align="left" rowspan="1" colspan="1">Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Paploski et al (2016)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Salvador (city)</td><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">Active surveillance and medical records review</td><td align="left" rowspan="1" colspan="1">Not specified</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Nobrega (2018)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Recife (metropolitan)</td><td align="left" rowspan="1" colspan="1">January-June, 2015</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0 &#x00026; Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Styczynski et al (2017)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Salvador (metropolitan)</td><td align="left" rowspan="1" colspan="1">April-July 2015</td><td align="left" rowspan="1" colspan="1">Passive state surveillance system and review of medical discharge records</td><td align="left" rowspan="1" colspan="1">Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">&#x02265;12</td></tr><tr><td align="left" rowspan="1" colspan="1">Department of Health of Paiu&#x000ed; State (2016)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Piau&#x000ed; (state)</td><td align="left" rowspan="1" colspan="1">November 2015-October 2016</td><td align="left" rowspan="1" colspan="1">Active hospital-based state surveillance system</td><td align="left" rowspan="1" colspan="1">Not specified</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Rivera-Lillo et al (2016)</td><td align="left" rowspan="1" colspan="1">Chile</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2001&#x02013;2012</td><td align="left" rowspan="1" colspan="1">Passive national surveillance system</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Machado-Alba et al (2016)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">March 2014-September 2015 October 2015-March 2016</td><td align="left" rowspan="1" colspan="1">Private insurance diagnostic database</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Anaya et al (2017)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">C&#x000fa;cuta (city)</td><td align="left" rowspan="1" colspan="1">June 2015-July 2016</td><td align="left" rowspan="1" colspan="1">Passive national surveillance system</td><td align="left" rowspan="1" colspan="1">Brighton Collaboration (1,2)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Tolosa et al (2017)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">August 2015-May 2016</td><td align="left" rowspan="1" colspan="1">Passive national surveillance system</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0</td><td align="left" rowspan="1" colspan="1">&#x02264;18</td></tr><tr><td align="left" rowspan="1" colspan="1">Instituto Nacional de Salud de Colombia (2016)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">October 2015-March 2016</td><td align="left" rowspan="1" colspan="1">Passive national surveillance system</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Salinas et al (2017)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Barranquilla (city)</td><td align="left" rowspan="1" colspan="1">October 2015-April 2016</td><td align="left" rowspan="1" colspan="1">Passive national and local surveillance systems and medical records review</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0 &#x00026; Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Hart et al (1994)</td><td align="left" rowspan="1" colspan="1">Paraguay</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">1990&#x02013;1991</td><td align="left" rowspan="1" colspan="1">National AFP surveillance and medical diagnosis</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">&#x0003c;15</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Caribbean</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Suryapranata et al (2016)</td><td align="left" rowspan="1" colspan="1">Aruba</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2003&#x02013;2011</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records</td><td align="left" rowspan="1" colspan="1">ICD-9 357.0 &#x00026; Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">van Koningsveld et al (2001)</td><td align="left" rowspan="1" colspan="1">Cura&#x000e7;ao</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">1987&#x02013;1999</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records</td><td align="left" rowspan="1" colspan="1">ICD-9 357.0 &#x00026; Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#x000fa;n&#x000f1;ez R et al (2017)</td><td align="left" rowspan="1" colspan="1">Dominican Republic</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">January 2016-October 2016</td><td align="left" rowspan="1" colspan="1">Passive national surveillance system</td><td align="left" rowspan="1" colspan="1">Brighton collaboration (1,2)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Balavoine et al (2017)</td><td align="left" rowspan="1" colspan="1">Guadeloupe and Martinique</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2011&#x02013;2013 2014 (chikungunya)</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records</td><td align="left" rowspan="1" colspan="1">ICD-9</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Roze et al (2017)</td><td align="left" rowspan="1" colspan="1">Martinique</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2006&#x02013;2016 2014 (chikungunya) 2016 (Zika)</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records and prospective medical evaluation</td><td align="left" rowspan="1" colspan="1">ICD-10 &#x00026; Brighton Collaboration (1,2)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Salinas et al (2017)</td><td align="left" rowspan="1" colspan="1">Puerto Rico</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2013</td><td align="left" rowspan="1" colspan="1">Retrospective review of medical discharge records and insurance claims</td><td align="left" rowspan="1" colspan="1">ICD-9357.0 or ICD-10 G61.0 and Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1">Dirlikov (2018)</td><td align="left" rowspan="1" colspan="1">Puerto Rico</td><td align="left" rowspan="1" colspan="1">Nationwide</td><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">National surveillance system followed by medical record review</td><td align="left" rowspan="1" colspan="1">ICD-10 G61.0 &#x00026; Brighton Collaboration (1&#x02013;3)</td><td align="left" rowspan="1" colspan="1">All</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Regional</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Oliv&#x000e9; et al (1997)</td><td align="left" rowspan="1" colspan="1">7 countries<xref ref-type="table-fn" rid="t001fn002"><sup>2</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1989&#x02013;1991</td><td align="left" rowspan="1" colspan="1">Passive AFP regional surveillance followed by neurologist diagnosis</td><td align="left" rowspan="1" colspan="1">Asbury &#x00026; Cornblath</td><td align="left" rowspan="1" colspan="1">&#x0003c;15</td></tr><tr><td align="left" rowspan="1" colspan="1">Silveira et al (1997)</td><td align="left" rowspan="1" colspan="1">4 countries<xref ref-type="table-fn" rid="t001fn003"><sup>3</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1990&#x02013;1994</td><td align="left" rowspan="1" colspan="1">Passive AFP regional surveillance followed by neurologist diagnosis</td><td align="left" rowspan="1" colspan="1">PAHO Polio Eradication Field Guide definition</td><td align="left" rowspan="1" colspan="1">&#x0003c;15</td></tr><tr><td align="left" rowspan="1" colspan="1">Landaverde et al (2010)</td><td align="left" rowspan="1" colspan="1">19 countries<xref ref-type="table-fn" rid="t001fn004"><sup>4</sup></xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2000&#x02013;2008</td><td align="left" rowspan="1" colspan="1">Passive AFP regional surveillance followed by neurologist diagnosis</td><td align="left" rowspan="1" colspan="1">PAHO Polio Eradication Field Guide definition</td><td align="left" rowspan="1" colspan="1">&#x0003c;15</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>1</sup> When two dates are given, the first is before and the second during the epidemic period</p></fn><fn id="t001fn002"><p><sup>2</sup> El Salvador, Guatemala, Honduras, Paraguay, Peru, Mexico, and Venezuela</p></fn><fn id="t001fn003"><p><sup>3</sup>Argentina, Brazil, Chile and Colombia</p></fn><fn id="t001fn004"><p><sup>4 </sup>Argentina, Brazil, Chile, Colombia, Cuba, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru, the Bahamas, Guyana, Jamaica, St Vincent and the Grenadines, Suriname, and Trinidad and Tobago</p></fn></table-wrap-foot></table-wrap><table-wrap id="pntd.0007622.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007622.t002</object-id><label>Table 2</label><caption><title>Annual incidence rate of Guillain-Barr&#x000e9; Syndrome in 31 selected studies, by location and epidemic status.</title></caption><alternatives><graphic id="pntd.0007622.t002g" xlink:href="pntd.0007622.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Author/s (Year)</th><th align="left" rowspan="1" colspan="1">Country</th><th align="left" rowspan="1" colspan="1">Epidemic arbovirus</th><th align="left" rowspan="1" colspan="1">Study duration (in years)</th><th align="left" rowspan="1" colspan="1">Incident cases</th><th align="left" rowspan="1" colspan="1">Mean annual cases</th><th align="left" rowspan="1" colspan="1">Population</th><th align="left" rowspan="1" colspan="1">Annual incidence rate per 100,000 persons (95% CI)<xref ref-type="table-fn" rid="t002fn001"><sup>1</sup></xref></th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1"><bold>Central America and Mexico</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">Background incidence rate (IR) of GBS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Molinero et al (2003)</td><td align="left" rowspan="1" colspan="1">Honduras</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11.0</td><td align="left" rowspan="1" colspan="1">394</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">2 627 737</td><td align="left" rowspan="1" colspan="1">1.37 (0.96&#x02013;1.90)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">de la Pe&#x000f1;a et al (2015)</td><td align="left" rowspan="1" colspan="1">Mexico</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.0</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">4 513 718</td><td align="left" rowspan="1" colspan="1">0.20 (0.09&#x02013;0.38)</td></tr><tr><td align="left" colspan="2" rowspan="1">IR during epidemic outbreak</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">del Carpio Orantes et al (2018)</td><td align="left" rowspan="1" colspan="1">Mexico</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">2 732 286</td><td align="left" rowspan="1" colspan="1">0.62 (0.36&#x02013;1.00)</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>South America</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">Background IR of GBS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rojas et al (2009)</td><td align="left" rowspan="1" colspan="1">Argentina</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.0</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">145 310</td><td align="left" rowspan="1" colspan="1">2.06 (0.43&#x02013;6.03)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Codeb&#x000f3; et al (2016)</td><td align="left" rowspan="1" colspan="1">Argentina</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.0</td><td align="left" rowspan="1" colspan="1">1 859</td><td align="left" rowspan="1" colspan="1">264</td><td align="left" rowspan="1" colspan="1">41 904 761</td><td align="left" rowspan="1" colspan="1">0.63 (0.56&#x02013;0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dias-Tosta et al (2002)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.0</td><td align="left" rowspan="1" colspan="1">1 678</td><td align="left" rowspan="1" colspan="1">240</td><td align="left" rowspan="1" colspan="1">52 111 801</td><td align="left" rowspan="1" colspan="1">0.46 (0.40&#x02013;0.52)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dourado et al (2012)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13.6</td><td align="left" rowspan="1" colspan="1">149</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">2 781 767</td><td align="left" rowspan="1" colspan="1">0.40 (0.20&#x02013;0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rocha et al (2004)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.0</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">3 000 000</td><td align="left" rowspan="1" colspan="1">0.40 (0.21&#x02013;0.70)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Barcellos et al (2017)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">7.4</td><td align="left" rowspan="1" colspan="1">2 407</td><td align="left" rowspan="1" colspan="1">325</td><td align="left" rowspan="1" colspan="1">54 711 473</td><td align="left" rowspan="1" colspan="1">0.59 (0.53&#x02013;0.66)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Rivera-Lillo et al (2016)</td><td align="left" rowspan="1" colspan="1">Chile</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">12.0</td><td align="left" rowspan="1" colspan="1">4 158</td><td align="left" rowspan="1" colspan="1">347</td><td align="left" rowspan="1" colspan="1">16 353 842</td><td align="left" rowspan="1" colspan="1">2.12 (1.90&#x02013;2.36)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Machado-Alba et al (2016)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.6</td><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">6 500 000</td><td align="left" rowspan="1" colspan="1">0.95 (0.73&#x02013;1.22)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Hart et al (1994)</td><td align="left" rowspan="1" colspan="1">Paraguay</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.0</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">1 747 703</td><td align="left" rowspan="1" colspan="1">1.09 (0.65&#x02013;1.70)</td></tr><tr><td align="left" colspan="2" rowspan="1">IR during epidemic outbreak</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Souza (2018)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1">73</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">2 927 711</td><td align="left" rowspan="1" colspan="1">0.82 (0.53&#x02013;1.22)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Paploski et al (2016)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">2 920 300</td><td align="left" rowspan="1" colspan="1">1.75 (1.30&#x02013;2.30)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nobrega (2018)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">3 890 145</td><td align="left" rowspan="1" colspan="1">2.26 (1.81&#x02013;2.79)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Styczynski et al (2017)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">192</td><td align="left" rowspan="1" colspan="1">3 428 571</td><td align="left" rowspan="1" colspan="1">5.60 (4.84&#x02013;6.45)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Barcellos et al (2017)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.42</td><td align="left" rowspan="1" colspan="1">377</td><td align="left" rowspan="1" colspan="1">905</td><td align="left" rowspan="1" colspan="1">56 445 105</td><td align="left" rowspan="1" colspan="1">1.60 (1.50&#x02013;1.71)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Department of Health of Piau&#x000ed; State (2016)</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">3 219 257</td><td align="left" rowspan="1" colspan="1">0.71 (0.45&#x02013;1.07)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Anaya et al (2017)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">1.1</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">656 380</td><td align="left" rowspan="1" colspan="1">4.11 (2.71&#x02013;5.98)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Tolosa et al (2017)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">16 236 326</td><td align="left" rowspan="1" colspan="1">0.31 (0.23&#x02013;0.41)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Machado-Alba et al (2016)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">142</td><td align="left" rowspan="1" colspan="1">6 500 000</td><td align="left" rowspan="1" colspan="1">2.18 (1.84&#x02013;2.57)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Instituto Nacional de Salud de Colombia (2016)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">270</td><td align="left" rowspan="1" colspan="1">563</td><td align="left" rowspan="1" colspan="1">49 529 208</td><td align="left" rowspan="1" colspan="1">1.14 (1.04&#x02013;1.23)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Salinas et al (2017)</td><td align="left" rowspan="1" colspan="1">Colombia</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">93</td><td align="left" rowspan="1" colspan="1">1 218 475</td><td align="left" rowspan="1" colspan="1">7.63 (6.16&#x02013;9.35)</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Caribbean</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">Background IR of GBS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Suryapranata et al (2016)</td><td align="left" rowspan="1" colspan="1">Aruba</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.0</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">100 000</td><td align="left" rowspan="1" colspan="1">4.00 (1.09&#x02013;10.24)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">van Koningsveld et al (2001)</td><td align="left" rowspan="1" colspan="1">Cura&#x000e7;ao</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">12.3</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">152 694</td><td align="left" rowspan="1" colspan="1">2.62 (0.71&#x02013;6.71)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Balavoine et al (2017)</td><td align="left" rowspan="1" colspan="1">Guadeloupe and Martinique</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">792 091</td><td align="left" rowspan="1" colspan="1">1.77 (0.97&#x02013;2.97)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Roze et al (2017)</td><td align="left" rowspan="1" colspan="1">Martinique</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10.0</td><td align="left" rowspan="1" colspan="1">105</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">378 243</td><td align="left" rowspan="1" colspan="1">2.12 (0.91&#x02013;4.17)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Salinas et al (2017)</td><td align="left" rowspan="1" colspan="1">Puerto Rico</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">3 595 839</td><td align="left" rowspan="1" colspan="1">1.70 (1.30&#x02013;2.18)</td></tr><tr><td align="left" colspan="2" rowspan="1">IR during epidemic outbreak</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">N&#x000fa;&#x000f1;ez R et al (2017)</td><td align="left" rowspan="1" colspan="1">Dominican Republic</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">559</td><td align="left" rowspan="1" colspan="1">671</td><td align="left" rowspan="1" colspan="1">10 075 045</td><td align="left" rowspan="1" colspan="1">6.66 (6.17&#x02013;7.18)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Balavoine et al (2017)</td><td align="left" rowspan="1" colspan="1">Guadeloupe and Martinique</td><td align="left" rowspan="1" colspan="1">Chikungunya</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">783 336</td><td align="left" rowspan="1" colspan="1">3.45 (2.27&#x02013;5.01)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Roze et al (2017)</td><td align="left" rowspan="1" colspan="1">Martinique</td><td align="left" rowspan="1" colspan="1">Chikungunya</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">378 243</td><td align="left" rowspan="1" colspan="1">3.97 (2.22&#x02013;6.54)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Roze et al (2017)</td><td align="left" rowspan="1" colspan="1">Martinique</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">385 103</td><td align="left" rowspan="1" colspan="1">9.35 (6.55&#x02013;12.94)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Dirlikov (2018)</td><td align="left" rowspan="1" colspan="1">Puerto Rico</td><td align="left" rowspan="1" colspan="1">Zika</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">123</td><td align="left" rowspan="1" colspan="1">123</td><td align="left" rowspan="1" colspan="1">3 411 307</td><td align="left" rowspan="1" colspan="1">3.61 (3.00&#x02013;4.30)</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Regional</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">Background IR of GBS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Oliv&#x000e9; et al (1997)</td><td align="left" rowspan="1" colspan="1">7 countries</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1">1527</td><td align="left" rowspan="1" colspan="1">509</td><td align="left" rowspan="1" colspan="1">55 934 066</td><td align="left" rowspan="1" colspan="1">0.91 (0.83&#x02013;0.99)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Silveira et al (1997)</td><td align="left" rowspan="1" colspan="1">4 countries</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.0</td><td align="left" rowspan="1" colspan="1">2 296</td><td align="left" rowspan="1" colspan="1">456</td><td align="left" rowspan="1" colspan="1">73 400 000</td><td align="left" rowspan="1" colspan="1">0.62 (0.57&#x02013;0.68)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Landaverde et al (2010)</td><td align="left" rowspan="1" colspan="1">Regional</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.0</td><td align="left" rowspan="1" colspan="1">10 486</td><td align="left" rowspan="1" colspan="1">1 165</td><td align="left" rowspan="1" colspan="1">142 086 721</td><td align="left" rowspan="1" colspan="1">0.82 (0.77&#x02013;0.87)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><sup>1</sup> Calculations based on annualized GBS cases and population reported in the paper or from raw data provided by authors.</p></fn></table-wrap-foot></table-wrap><sec id="sec010"><title>Background GBS incidence rates</title><p>Among the studies in Latin America that reported background GBS IRs in all ages, the highest were reported in Chile (2.12 per 100,000; 95% CI 1.90&#x02013;2.36)[<xref rid="pntd.0007622.ref044" ref-type="bibr">44</xref>] and Argentina (2.06 per 100,000; 95% CI 0.43&#x02013;6.03) [<xref rid="pntd.0007622.ref039" ref-type="bibr">39</xref>], and the lowest in Brazil (0.40 per 100,000; 95% CI 0.20&#x02013;0.71)[<xref rid="pntd.0007622.ref042" ref-type="bibr">42</xref>] (<xref ref-type="fig" rid="pntd.0007622.g002">Fig 2</xref>). High heterogeneity in Latin America and in other subgroup analyses precluded us from pooling the proportions. The pooled annual IR in the Caribbean was 1.64 per 100,000 (95% CI 1.29&#x02013;2.12, <italic>I</italic><sup><italic>2</italic></sup> = 0.00, p = 0.44) (<xref ref-type="fig" rid="pntd.0007622.g003">Fig 3</xref>).</p><fig id="pntd.0007622.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007622.g002</object-id><label>Fig 2</label><caption><title>Annual background incidence rates of GBS by age in Latin America per 100,000 persons.</title></caption><graphic xlink:href="pntd.0007622.g002"/></fig><fig id="pntd.0007622.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007622.g003</object-id><label>Fig 3</label><caption><title>Annual and pooled background incidence rates of GBS in the Caribbean per 100,000 persons.</title></caption><graphic xlink:href="pntd.0007622.g003"/></fig><p>There were large annual fluctuations in GBS IRs in any given geographic location. In Chile, over a 12-year period, IRs ranged from 1.61 per 100,000 (n = 250 cases) in 2001 to 2.35 per 100,000 (n = 402 cases) in 2010 [<xref rid="pntd.0007622.ref044" ref-type="bibr">44</xref>]. Over a 14-year period, Dourado et al. [<xref rid="pntd.0007622.ref042" ref-type="bibr">42</xref>] reported a range of 0.12 to 0.66 per 100,000 in Rio Grande do Norte, Brazil. Another multi-year study from Brazil estimated mean annual IRs of 0.4 per 100,000 (range, 0.3&#x02013;0.6) [<xref rid="pntd.0007622.ref043" ref-type="bibr">43</xref>]. In the Caribbean island of Aruba, over an 11-year period, Suryapranata et al. reported a range of 1 to 11 cases of GBS, the latter occurring during an outbreak of <italic>C</italic>. <italic>jejuni</italic> (IRs ranged 1.0&#x02013;10.37 per 100,000). There was less fluctuation in IRs in Argentina, ranging from 0.56 per 100,000 in 2011 to 0.76 per 100,000 in 2010 over a 7-year period [<xref rid="pntd.0007622.ref040" ref-type="bibr">40</xref>]. However, the IR of GBS among members of a private health maintenance organization in Buenos Aires averaged 1.99 per 100,000 over an 8-year period [<xref rid="pntd.0007622.ref039" ref-type="bibr">39</xref>].</p></sec><sec id="sec011"><title>GBS incidence rates in children</title><p>Of the studies reporting background IRs in children under 15, the lowest rates were in Brazil at 0.40 per 100,000 [<xref rid="pntd.0007622.ref018" ref-type="bibr">18</xref>], followed by Paraguay at 0.72 per 100,000 [<xref rid="pntd.0007622.ref045" ref-type="bibr">45</xref>], and the highest rates in El Salvador at 3.86 per 100,000 [<xref rid="pntd.0007622.ref018" ref-type="bibr">18</xref>], Chile at 1.63 per 100,000 [<xref rid="pntd.0007622.ref018" ref-type="bibr">18</xref>], and Honduras at 1.37 per 100,000 [<xref rid="pntd.0007622.ref037" ref-type="bibr">37</xref>].</p><p>The age-specific distribution of GBS in the pediatric population varied widely across countries. Two multi-country studies found the highest GBS IR in the 1&#x02212;4 age group: Oliv&#x000e9; et al. reported that 47% of the GBS cases were in children 1&#x02212;4 years of age [<xref rid="pntd.0007622.ref035" ref-type="bibr">35</xref>] and Silveira et al. reported an average IR of 0.86 per 100,000 (95% CI 0.78&#x02013;0.89) in this age group as compared to 0.52 per 100,000 (95% CI 0.49&#x02013;0.53) among 5&#x02212;14 year-olds [<xref rid="pntd.0007622.ref036" ref-type="bibr">36</xref>]. In Paraguay, the IRs ranged from 1.7 per 100,000 among 1&#x02212;4 year-olds to 0.1 per 100,000 among 10&#x02212;14 year-olds [<xref rid="pntd.0007622.ref045" ref-type="bibr">45</xref>]. In Brazil, a similar trend was reported, with 40% of the cases reported in children under 5 [<xref rid="pntd.0007622.ref041" ref-type="bibr">41</xref>]. However, in Chile the IRs were higher among 5&#x02212;9 year-old children (2.23 per 100,000) than among 0&#x02212;4 year&#x02212;olds (2.17 per 100,000) [<xref rid="pntd.0007622.ref044" ref-type="bibr">44</xref>].</p></sec><sec id="sec012"><title>Distribution of GBS by age in the population as a whole</title><p>GBS distribution by age in the general population did not follow a consistent pattern across countries. In Chile, the IR showed a bimodal distribution with a peak in the youngest ages (2.23 per 100,000 in 5&#x02212;9 year-olds), and increased from 1.22 per 100,000 among 20&#x02212;29 year-olds to 4.30 per 100,000 among 70&#x02212;79 years-olds [<xref rid="pntd.0007622.ref044" ref-type="bibr">44</xref>]. In S&#x000e3;o Paulo, Brazil, GBS was most common among 15&#x02212;40 year-olds (0.15 per 100,000), and the IR was lowest in the over 60 (0.60 per 100,000) and under 15 (0.80 per 100,000) age groups [<xref rid="pntd.0007622.ref043" ref-type="bibr">43</xref>]. In Rio Grande do Norte, Brazil, half of the cases were recorded among under 20 years-olds [<xref rid="pntd.0007622.ref042" ref-type="bibr">42</xref>]. In Argentina, 37% of the GBS cases were reported in children under 14 years of age [<xref rid="pntd.0007622.ref040" ref-type="bibr">40</xref>]. Reporting of higher IRs among children might be due to higher case detection resulting from vaccination safety and polio eradication surveillance efforts.</p></sec><sec id="sec013"><title>Sex differences</title><p>Studies consistently found a higher burden of GBS among males. In studies of children 15 years of age and younger, the highest male-to-female ratio was documented in El Salvador (1.8:1) [<xref rid="pntd.0007622.ref035" ref-type="bibr">35</xref>] and the lowest in Brazil (1.2:1) [<xref rid="pntd.0007622.ref041" ref-type="bibr">41</xref>] and Honduras 1.3:1 [<xref rid="pntd.0007622.ref037" ref-type="bibr">37</xref>]. Among all ages, the highest male-to-female ratio was documented in Aruba (2.3:1) [<xref rid="pntd.0007622.ref046" ref-type="bibr">46</xref>], followed by Argentina (1.6:1) [<xref rid="pntd.0007622.ref040" ref-type="bibr">40</xref>], and the lowest in Brazil (1.3:1) [<xref rid="pntd.0007622.ref042" ref-type="bibr">42</xref>].</p></sec><sec id="sec014"><title>GBS and arboviral infections</title><p>We found that 17 studies reported the GBS IR during arboviral disease outbreaks in seven countries; 14 during the 2015&#x02013;2016 ZIKV epidemic, one during the 2014 CHIKV outbreak in the French West Indies, and 1 during DENV, CHIKV and ZIKV outbreaks in Martinique (See <xref ref-type="fig" rid="pntd.0007622.g004">Fig 4</xref>). The IR in the French West Indies during the 2014 CHIKV epidemic was 3.45 per 100,000 persons [<xref rid="pntd.0007622.ref027" ref-type="bibr">27</xref>], representing a two-fold increase from 1.77 per 100,000 during 2011&#x02013;2013 (p = 0.006) [<xref rid="pntd.0007622.ref027" ref-type="bibr">27</xref>]. The IR in Martinique increased by 4.4 times to 9.35 per 100,000 during the ZIKV epidemic from a mean annual IR of 2.12 per 100,000 during 2006&#x02013;2015 [Incidence rate ratio (IRR) <sub>(2016 vs. 2006&#x02013;2015)</sub> = 4.52; 95% CI 2.80&#x02013;7.64] [<xref rid="pntd.0007622.ref062" ref-type="bibr">62</xref>]. In Puerto Rico, the IR increased by 2.1 times during the ZIKV epidemic from 1.7 to 3.5 per 100,000 [IRR <sub>(2016 vs. 2012&#x02013;2015)</sub> = 2.06; 95% CI 1.51&#x02013;2.85] [<xref rid="pntd.0007622.ref048" ref-type="bibr">48</xref>, <xref rid="pntd.0007622.ref063" ref-type="bibr">63</xref>].</p><fig id="pntd.0007622.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0007622.g004</object-id><label>Fig 4</label><caption><title>Annualized incidence rates of GBS by sub-region during arboviral epidemic outbreaks.</title></caption><graphic xlink:href="pntd.0007622.g004"/></fig><p>In South America, there was substantial heterogeneity in the GBS IRs during the 2015&#x02212;2016 ZIKV epidemic for the population as a whole, ranging from 7.63 per 100,000 in Barranquilla, Colombia [<xref rid="pntd.0007622.ref058" ref-type="bibr">58</xref>], to 0.71 per 100,000 in the Brazilian state of Piau&#x000ed; [<xref rid="pntd.0007622.ref054" ref-type="bibr">54</xref>]. In a multi-year study, Barcellos et al. reported a 2.7 (IRR <sub>(2015&#x02013;2016 vs. 2008&#x02013;2015)</sub> = 2.7; 95% CI 2.38&#x02013;3.07) increase in the rate of GBS hospitalizations in Brazil&#x02019;s Northeast region during the peak of the ZIKV epidemic as compared to the mean rate in the eight years preceding the epidemic [<xref rid="pntd.0007622.ref060" ref-type="bibr">60</xref>]. In Colombia, Machado et al. reported over a two-fold increase in GBS diagnoses during the peak of the ZIKV epidemic as compared to baseline rates (IRR <sub>(2016 vs. 2014&#x02013;2015)</sub> = 2.29; 95% CI 1.69&#x02013;3.14) [<xref rid="pntd.0007622.ref061" ref-type="bibr">61</xref>].</p><p>In Veracruz, Mexico, del Carpio Orantes reported a GBS IR of 0.62 per 100,000 during the ZIKV epidemic in 2016 [<xref rid="pntd.0007622.ref049" ref-type="bibr">49</xref>].</p><p>We performed sub-group analyses by case-ascertainment (i.e., administrative data based on ICD codes only versus both administrative data and medical record review) to assess if the IR heterogeneity was due to this factor. We found significant within-group heterogeneity but not between-group heterogeneity, indicating that case ascertainment did not significantly bias the IRs. This held true when we performed a region-wide analysis, and when we analyzed Latin American and the Caribbean sub-regions separately (See <xref ref-type="supplementary-material" rid="pntd.0007622.s004">S1 Fig</xref>).</p></sec></sec><sec sec-type="conclusions" id="sec015"><title>Discussion</title><p>The pooled background IR of GBS calculated in the Caribbean of 1.64 per 100,000 (95% CI 1.29&#x02013;2.12, <italic>I</italic><sup><italic>2</italic></sup> = 0.00, p = 0.44) was higher than the mean IR in North America and Europe but within the estimated range for those regions (0.80&#x02212;1.90 per 100,000) [<xref rid="pntd.0007622.ref013" ref-type="bibr">13</xref>]. In LAC, background IRs of GBS ranged from 0.40 per 100,000 in Rio Grande do Norte [<xref rid="pntd.0007622.ref042" ref-type="bibr">42</xref>] and S&#x000e3;o Paulo [<xref rid="pntd.0007622.ref043" ref-type="bibr">43</xref>] in Brazil to 2.12 per 100,000 in Chile [<xref rid="pntd.0007622.ref044" ref-type="bibr">44</xref>]. These background IRs exceeded the upper and lower ranges calculated by the aforementioned meta-analysis [<xref rid="pntd.0007622.ref013" ref-type="bibr">13</xref>], but were comparable to the range reported in a 2009 GBS literature review from 0.38/100,000/year in Finland to 2.53/100,000/year in Cura&#x000e7;ao [<xref rid="pntd.0007622.ref014" ref-type="bibr">14</xref>].</p><p>Sejvar et al. found that the incidence of GBS increased with age [<xref rid="pntd.0007622.ref013" ref-type="bibr">13</xref>]. However, we did not observe similar trends in the LAC population, with the GBS IR exhibiting different age-specific patterns across settings. The higher burden of GBS among males reported in this review was consistent with Sejvar et al., with an estimated relative risk for males of 1.78 (95% CI 1.36&#x02013;2.33) [<xref rid="pntd.0007622.ref013" ref-type="bibr">13</xref>].</p><p>This review synthesizes GBS incidence data from CHIKV and ZIKV epidemic outbreaks. However, data on CHIKV infection and GBS are limited to the French West Indies. The association of DENV infection with GBS is not well established. One multi-year study in Aruba found a positive correlation between number of GBS cases and laboratory-confirmed DENV infections (p = 0.004, Kendall&#x02019;s tau-b) [<xref rid="pntd.0007622.ref046" ref-type="bibr">46</xref>]. However, a study from Brazil reported no association between DENV outbreaks and GBS [<xref rid="pntd.0007622.ref064" ref-type="bibr">64</xref>]. More data are needed on incidence of GBS during CHIKV and DENV outbreaks in the region. In terms of ZIKV, most studies showed temporal associations of ZIKV infections with GBS rates. However, fewer studies reported GBS rates at baseline and during an outbreak, in part because of sparse historical data on GBS. Dos Santos et al. reported increases in IRs during the weeks of ZIKV transmission ranging from 100% in El Salvador (95% CI 55.7&#x02013;156.9) to 877% in Venezuela (95% CI 664.1&#x02013;1149.6) as compared to estimated pre-ZIKV baselines [<xref rid="pntd.0007622.ref025" ref-type="bibr">25</xref>]. Consistent with Dos Santos et al., studies that reported rates of GBS at baseline and during epidemic weeks reported increases of 106% in Puerto Rico (IRR <sub>(2016 vs. 2012&#x02013;2015)</sub> = 2.06; 95% CI 1.51&#x02013;2.85), 352% in Martinique (IRR <sub>(2016 vs. 2006&#x02013;2015)</sub> = 4.52; 95% CI 2.80&#x02013;7.64), 171% in Brazil&#x02019;s Northeastern region (IRR <sub>(2015&#x02013;2016 vs. 2008&#x02013;2015)</sub> = 2.7; 95% CI 2.38&#x02013;3.07), and 129% in Colombia (IRR <sub>(2016 vs. 2014&#x02013;2015)</sub> = 2.29; 95% CI 1.69&#x02013;3.14). In summary, all studies that reported rates of GBS before and during the ZIKV outbreak showed significant temporal increases in IRs during the outbreak. However, this could be due to publication bias. Furthermore, heterogeneity coupled with limited data precludes us from drawing region-wide comparisons of these differences.</p><p>ZIKV emerged in an immunologically naive population and spread rapidly throughout the Americas, with the consequent impact on human health [<xref rid="pntd.0007622.ref065" ref-type="bibr">65</xref>]. In the upcoming years it is unlikely that the region will experience similar peaks of GBS due to ZIKV infection given the build-up of population immunity against this arbovirus [<xref rid="pntd.0007622.ref066" ref-type="bibr">66</xref>]. However, other emerging pathogens, including different arboviruses and influenza strains [<xref rid="pntd.0007622.ref067" ref-type="bibr">67</xref>], may trigger increases in the incidence of GBS. In the future, in addition to background GBS-triggering foodborne infections, we expect GBS incidence to be cyclical as attack rates of arboviral infections fluctuate seasonally as well as in response to population immunity. Foodborne infections are often cited as the most common GBS trigger, responsible for between 25% and 50% of GBS cases worldwide [<xref rid="pntd.0007622.ref001" ref-type="bibr">1</xref>]. Of eight studies included in this review that examined <italic>C</italic>. <italic>jejuni</italic> as an antecedent infection to GBS, only two found a positive association. On the island of Cura&#x000e7;ao, authors found a positive temporal association between <italic>C</italic>. <italic>jejuni</italic> infections and GBS in pre-ZIKV years (1987&#x02013;1999) [<xref rid="pntd.0007622.ref047" ref-type="bibr">47</xref>]. In Veracruz, Mexico, 75% of GBS patients tested positive for <italic>C</italic>. <italic>jejuni</italic> infection in 2017 (after the peak of ZIKV) [<xref rid="pntd.0007622.ref049" ref-type="bibr">49</xref>]. Studies in Aruba, Brazil, and Colombia&#x02013;all except the one from Aruba were conducted during the ZIKV epidemic&#x02013;found no association between <italic>C</italic>. <italic>jejuni</italic> infection and GBS [<xref rid="pntd.0007622.ref043" ref-type="bibr">43</xref>, <xref rid="pntd.0007622.ref046" ref-type="bibr">46</xref>, <xref rid="pntd.0007622.ref050" ref-type="bibr">50</xref>, <xref rid="pntd.0007622.ref052" ref-type="bibr">52</xref>, <xref rid="pntd.0007622.ref055" ref-type="bibr">55</xref>, <xref rid="pntd.0007622.ref058" ref-type="bibr">58</xref>]. A study in Brazil found respiratory infections to be present in 27% of GBS patients compared to 7% with gastrointestinal infections in pre-ZIKV years (1995&#x02013;2002) [<xref rid="pntd.0007622.ref043" ref-type="bibr">43</xref>]. Although examining the role of foodborne infections was outside the scope of this research, this limited evidence suggests that temporal increases in GBS incidence during ZIKV in LAC are not associated with <italic>C</italic>. <italic>jejuni</italic> infection. With more robust GBS surveillance and increased awareness, the region would be better prepared to monitor fluctuations in GBS incidence in the future. Although this review focused on GBS in endemic populations, incidence of neurological conditions in other regions might be impacted by international travelers returning from areas with ZIKV and other arboviral disease transmission, or with a sexual partner who returned from such areas [<xref rid="pntd.0007622.ref068" ref-type="bibr">68</xref>&#x02013;<xref rid="pntd.0007622.ref076" ref-type="bibr">76</xref>].</p><sec id="sec016"><title>Strengths and limitations</title><p>Data on GBS, both historical and current, are lacking for many countries in the region. With the exception of studies using AFP data, most are recent and from ZIKV-affected countries, and baseline data are often lacking. Publication bias in favor of significant results may have limited the availability of studies that found no association between arboviral epidemics and GBS. On the other hand, ZIKV&#x02019;s high public visibility most likely led to increased scientific research and publications on GBS as well as surveillance (i.e., detection) bias, particularly in countries affected by the emerging arbovirus. Few studies reported data from Central America and Mexico. Therefore, estimates for this sub-region have a high risk of bias. All but two studies reported effect sizes for the outcome of interest. However, we addressed this limitation by calculating 95% confidence intervals for all studies.</p><p>Methodological differences in case finding limit comparability across studies. The specificity and sensitivity of administrative data varies by setting [<xref rid="pntd.0007622.ref048" ref-type="bibr">48</xref>, <xref rid="pntd.0007622.ref077" ref-type="bibr">77</xref>]. Rates of GBS based on administrative records or passive surveillance systems, without medical record review, may be prone to over-reporting [<xref rid="pntd.0007622.ref048" ref-type="bibr">48</xref>] and under-reporting [<xref rid="pntd.0007622.ref035" ref-type="bibr">35</xref>, <xref rid="pntd.0007622.ref078" ref-type="bibr">78</xref>], respectively. We opted to include surveillance and administrative data because of the paucity of data available. The high cost of capture-recapture methods to compare sensitivity of case identification and ascertainment methods of a rare syndrome limits the feasibility of such studies to assess GBS incidence nationwide. Several researchers have accepted the use of administrative data as a viable low-cost option to assess background GBS IRs [<xref rid="pntd.0007622.ref040" ref-type="bibr">40</xref>, <xref rid="pntd.0007622.ref044" ref-type="bibr">44</xref>].</p><p>A limitation of this review is that studies employed different methodologies to ascertain GBS cases. Diagnosing GBS is complex and based on clinical observation and electrophysiological studies. Specialists who can properly diagnose GBS may be unavailable in resource-limited settings. Natural annual variations in incidence may be masked or exacerbated by imperfect case identification.</p><p>A strength of this research is that all included studies are population based. In addition, many of the studies are multi-year in duration, with a mean of 7.2 years for studies that analyzed background GBS IRs. This gives us a robust estimate of GBS incidence that balances out natural fluctuations in annual IRs. Another strength is the application of a thorough search methodology and inclusion of most languages spoken in LAC. Inclusion of ministry of health bulletins data served to balance publication bias.</p><p>Some of the included studies were not carried out with the sole purpose of measuring GBS IRs. While the studies that focused on IR calculations tended to adjust the rates based on population age structures, others did not. This introduces a source of variability. Some studies reported incidence by person-years and others as annual incidence. We addressed this issue by calculating all IRs.</p><p>Since GBS is triggered by a variety of antecedent infections, baseline incidence of GBS is critical for detecting and monitoring infectious disease outbreaks. The LAC region has been a pioneer in monitoring of GBS in children over the last 30 years [<xref rid="pntd.0007622.ref016" ref-type="bibr">16</xref>]. Countries such as Colombia and Brazil have monitored GBS as part of DENV eradication programs [<xref rid="pntd.0007622.ref057" ref-type="bibr">57</xref>, <xref rid="pntd.0007622.ref079" ref-type="bibr">79</xref>]. The ZIKV epidemic and the reported increases in GBS in the Americas have made GBS a notifiable condition in many countries. As the ZIKV epidemic has spread beyond the Americas [<xref rid="pntd.0007622.ref080" ref-type="bibr">80</xref>&#x02013;<xref rid="pntd.0007622.ref082" ref-type="bibr">82</xref>], it is important that those countries are particularly prepared for GBS surveillance and management. Enhanced surveillance and increased research have provided us with new data to assess GBS incidence in this region. Because of its severity and lethality in the absence of adequate care, investments are needed to provide information on GBS to populations at-risk and to build healthcare providers&#x02019; capacity to diagnose GBS and follow appropriate care protocols [<xref rid="pntd.0007622.ref083" ref-type="bibr">83</xref>, <xref rid="pntd.0007622.ref084" ref-type="bibr">84</xref>]. GBS poses an additional burden to health care systems, particularly in resource-limited settings.</p></sec></sec><sec sec-type="supplementary-material" id="sec017"><title>Supporting information</title><supplementary-material content-type="local-data" id="pntd.0007622.s001"><label>S1 File</label><caption><title>PRISMA checklist.</title><p>(DOC)</p></caption><media xlink:href="pntd.0007622.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007622.s002"><label>S2 File</label><caption><title>MOOSE checklist.</title><p>(PDF)</p></caption><media xlink:href="pntd.0007622.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007622.s003"><label>S3 File</label><caption><title>Detailed search strategy.</title><p>(DOCX)</p></caption><media xlink:href="pntd.0007622.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007622.s004"><label>S1 Fig</label><caption><title>Sub-group analysis by case ascertainment.</title><p>Sub-group analysis by case ascertainment: administrative data and medical record review versus ICD code only.</p><p>(PDF)</p></caption><media xlink:href="pntd.0007622.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0007622.s005"><label>S2 Fig</label><caption><title>Risk of bias in GBS observational studies.</title><p>Risk of bias in GBS observational studies.</p><p>(PDF)</p></caption><media xlink:href="pntd.0007622.s005.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors wish to thank Christovam Barcellos, PhD (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil), Amilton Antunes Barreira, MD, PhD (Universidade de S&#x000e3;o Paulo, Sao Paulo, Brazil), Luis del Carpio Orantes, MD (Instituto Mexicano del Seguro Social, Veracruz, Mexico), Mario E. T. Dourado Jr., MD, MSc (Hospital Universitario Onofre Lopes/Universidade Federal do Rio Grande do Norte, Natal, Brazil), Jorge E. Machado-Alba, MD, PhD (Universidad Tecnol&#x000f3;gica de Pereira-Audifarma S.A., Pereira, Colombia), Salim M&#x000e1;ttar, PhD (Universidad de C&#x000f3;rdoba, Monter&#x000ed;a, Colombia), Franciska S. T. Suryapranata, MS (VU University Medical Centre, Amsterdam, The Netherlands), and Arnold R. Thompson Cerna, MD (Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras) for providing additional information about their studies.</p></ack><ref-list><title>References</title><ref id="pntd.0007622.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Willison</surname><given-names>HJ</given-names></name>, <name><surname>Jacobs</surname><given-names>BC</given-names></name>, <name><surname>van Doorn</surname><given-names>PA</given-names></name>. <article-title>Guillain-Barre syndrome</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>388</volume>(<issue>10045</issue>):<fpage>717</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00339-1</pub-id>
<?supplied-pmid 26948435?><pub-id pub-id-type="pmid">26948435</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Van Den Berg</surname><given-names>B</given-names></name>, <name><surname>Walgaard</surname><given-names>C</given-names></name>, <name><surname>Drenthen</surname><given-names>J</given-names></name>, <name><surname>Fokke</surname><given-names>C</given-names></name>, <name><surname>Jacobs</surname><given-names>BC</given-names></name>, <name><surname>Van Doorn</surname><given-names>PA</given-names></name>. <article-title>Guillain-Barre syndrome: Pathogenesis, diagnosis, treatment and prognosis</article-title>. <source>Nature Reviews Neurology</source>. <year>2014</year>;<volume>10</volume>(<issue>8</issue>):<fpage>469</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.121</pub-id>
<?supplied-pmid 25023340?><pub-id pub-id-type="pmid">25023340</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>AHY</given-names></name>, <name><surname>Umapathi</surname><given-names>T</given-names></name>, <name><surname>Shahrizaila</surname><given-names>N</given-names></name>, <name><surname>Chan</surname><given-names>YC</given-names></name>, <name><surname>Kokubun</surname><given-names>N</given-names></name>, <name><surname>Fong</surname><given-names>MK</given-names></name>, <etal>et al</etal>
<article-title>The value of comparing mortality of Guillain-Barre syndrome across different regions</article-title>. <source>J Neurol Sci</source>. <year>2014</year>;<volume>344</volume>(<issue>1&#x02013;2</issue>):<fpage>60</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2014.06.021</pub-id>
<?supplied-pmid 24993467?><pub-id pub-id-type="pmid">24993467</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Darweesh</surname><given-names>SK</given-names></name>, <name><surname>Polinder</surname><given-names>S</given-names></name>, <name><surname>Mulder</surname><given-names>MJ</given-names></name>, <name><surname>Baena</surname><given-names>CP</given-names></name>, <name><surname>van Leeuwen</surname><given-names>N</given-names></name>, <name><surname>Franco</surname><given-names>OH</given-names></name>, <etal>et al</etal>
<article-title>Health-related quality of life in Guillain-Barre syndrome patients: a systematic review</article-title>. <source>J Peripher Nerv Syst</source>. <year>2014</year>;<volume>19</volume>(<issue>1</issue>):<fpage>24</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1111/jns5.12051</pub-id>
<?supplied-pmid 24456426?><pub-id pub-id-type="pmid">24456426</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>BC</given-names></name>, <name><surname>Van Den Berg</surname><given-names>B</given-names></name>, <name><surname>Verboon</surname><given-names>C</given-names></name>, <name><surname>Chavada</surname><given-names>G</given-names></name>, <name><surname>Cornblath</surname><given-names>DR</given-names></name>, <name><surname>Gorson</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>International Guillain-Barr&#x000e9; Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr&#x000e9; syndrome</article-title>. <source>J Peripher Nerv Syst</source>. <year>2017</year>;<volume>22</volume>(<issue>2</issue>):<fpage>68</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/jns.12209</pub-id>
<?supplied-pmid 28406555?><pub-id pub-id-type="pmid">28406555</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Kogos</surname><given-names>SC</given-names><suffix>Jr</suffix></name>, <name><surname>Richards</surname><given-names>JS</given-names></name>, <name><surname>Banos</surname><given-names>J</given-names></name>, <name><surname>Schmitt</surname><given-names>MM</given-names></name>, <name><surname>Brunner</surname><given-names>RC</given-names></name>, <name><surname>Meythaler</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>A descriptive study of pain and quality of life following Guillain-Barre syndrome: One year later</article-title>. <source>J Clin Psychol Med Settings</source>. <year>2005</year>;<volume>12</volume>(<issue>2</issue>):<fpage>111</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="pntd.0007622.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Bersano</surname><given-names>A</given-names></name>, <name><surname>Carpo</surname><given-names>M</given-names></name>, <name><surname>Allaria</surname><given-names>S</given-names></name>, <name><surname>Franciotta</surname><given-names>D</given-names></name>, <name><surname>Citterio</surname><given-names>A</given-names></name>, <name><surname>Nobile-Orazio</surname><given-names>E</given-names></name>. <article-title>Long term disability and social status change after Guillain-Barre syndrome</article-title>. <source>J Neurol</source>. <year>2006</year>;<volume>253</volume>(<issue>2</issue>):<fpage>214</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-005-0958-x</pub-id>
<?supplied-pmid 16096809?><pub-id pub-id-type="pmid">16096809</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Ruts</surname><given-names>L</given-names></name>, <name><surname>Drenthen</surname><given-names>J</given-names></name>, <name><surname>Jongen</surname><given-names>JLM</given-names></name>, <name><surname>Hop</surname><given-names>WCJ</given-names></name>, <name><surname>Visser</surname><given-names>GH</given-names></name>, <name><surname>Jacobs</surname><given-names>BC</given-names></name>, <etal>et al</etal>
<article-title>Pain in Guillain-Barre syndrome A long-term follow-up study</article-title>. <source>Neurology</source>. <year>2010</year>;<volume>75</volume>(<issue>16</issue>):<fpage>1439</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f88345</pub-id>
<?supplied-pmid 20861454?><pub-id pub-id-type="pmid">20861454</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Van Den Berg</surname><given-names>B</given-names></name>, <name><surname>Bunschoten</surname><given-names>C</given-names></name>, <name><surname>Van Doorn</surname><given-names>PA</given-names></name>, <name><surname>Jacobs</surname><given-names>BC</given-names></name>. <article-title>Mortality in Guillain-Barre syndrome</article-title>. <source>Neurology</source>. <year>2013</year>;<volume>80</volume>(<issue>18</issue>):<fpage>1650</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182904fcc</pub-id>
<?supplied-pmid 23576619?><pub-id pub-id-type="pmid">23576619</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ishaque</surname><given-names>T</given-names></name>, <name><surname>Islam</surname><given-names>MB</given-names></name>, <name><surname>Ara</surname><given-names>G</given-names></name>, <name><surname>Endtz</surname><given-names>HP</given-names></name>, <name><surname>Mohammad</surname><given-names>QD</given-names></name>, <name><surname>Jacobs</surname><given-names>BC</given-names></name>, <etal>et al</etal>
<article-title>High mortality from Guillain-Barr&#x000e9; syndrome in Bangladesh</article-title>. <source>J Peripher Nerv Syst</source>. <year>2017</year>;<volume>22</volume>(<issue>2</issue>):<fpage>121</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/jns.12215</pub-id>
<?supplied-pmid 28447405?><pub-id pub-id-type="pmid">28447405</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Benamer</surname><given-names>HTS</given-names></name>, <name><surname>Bredan</surname><given-names>A</given-names></name>. <article-title>Guillain-Barre syndrome in Arab countries: A systematic review</article-title>. <source>J Neurol Sci</source>. <year>2014</year>;<volume>343</volume>(<issue>1&#x02013;2</issue>):<fpage>221</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2014.05.065</pub-id>
<?supplied-pmid 24950899?><pub-id pub-id-type="pmid">24950899</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Frenzen</surname><given-names>PD</given-names></name>. <article-title>Economic cost of Guillain-Barre syndrome in the United States</article-title>. <source>Neurology</source>. <year>2008</year>;<volume>71</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000316393.54258.d1</pub-id>
<?supplied-pmid 18591502?><pub-id pub-id-type="pmid">18591502</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sejvar</surname><given-names>JJ</given-names></name>, <name><surname>Baughman</surname><given-names>AL</given-names></name>, <name><surname>Wise</surname><given-names>M</given-names></name>, <name><surname>Morgan</surname><given-names>OW</given-names></name>. <article-title>Population incidence of Guillain-Barre syndrome: A systematic review and meta-analysis</article-title>. <source>Neuroepidemiology</source>. <year>2011</year>;<volume>36</volume>(<issue>2</issue>):<fpage>123</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1159/000324710</pub-id>
<?supplied-pmid 21422765?><pub-id pub-id-type="pmid">21422765</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>McGrogan</surname><given-names>A</given-names></name>, <name><surname>Madle</surname><given-names>GC</given-names></name>, <name><surname>Seaman</surname><given-names>HE</given-names></name>, <name><surname>De Vries</surname><given-names>CS</given-names></name>. <article-title>The epidemiology of Guillain-Barre syndrome worldwide: A systematic literature review</article-title>. <source>Neuroepidemiology</source>. <year>2009</year>;<volume>32</volume>(<issue>2</issue>):<fpage>150</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1159/000184748</pub-id>
<?supplied-pmid 19088488?><pub-id pub-id-type="pmid">19088488</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref015"><label>15</label><mixed-citation publication-type="journal"><collab>Pan American Health Organization.</collab>
<article-title>Polio eradication to be reviewed in August</article-title>. <year>1994</year> 1994-<month>6</month> Report No.: 0251&#x02013;4710 <?supplied-pmid 12345536?><pub-id pub-id-type="pmid">12345536</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Quadros</surname><given-names>CA</given-names></name>, <name><surname>Hersh</surname><given-names>BS</given-names></name>, <name><surname>Olive</surname><given-names>JA</given-names></name>, <name><surname>Andrus</surname><given-names>JK</given-names></name>, <article-title>Silveira CMd, Carrasco PA. Eradication of Wild Poliovirus from the Americas: Acute Flaccid Paralysis Surveillance, 1988&#x02013;1995</article-title>. <source>J Infect Dis</source>. <year>1997</year>;<volume>175</volume>((<issue>Suppll</issue>)):<fpage>S37</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">9203690</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref017"><label>17</label><mixed-citation publication-type="journal"><collab>Pan American Health Organization</collab>. <article-title>Director announces campaign to eradicate poliomyelitis from the Americas by 1990</article-title>. <source>Bull Pan Am Health Organ</source>. <year>1985</year>;<volume>19</volume>:<fpage>213</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="pntd.0007622.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Landaverde</surname><given-names>JM</given-names></name>, <name><surname>Danovaro-Holliday</surname><given-names>MC</given-names></name>, <name><surname>Trumbo</surname><given-names>SP</given-names></name>, <name><surname>Pacis-Tirso</surname><given-names>CL</given-names></name>, <name><surname>Ruiz-Matus</surname><given-names>C</given-names></name>. <article-title>Guillain-Barr&#x000e9; Syndrome in Children Aged &#x0003c;15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) Pandemic.</article-title>
<source>J Infect Dis</source>. <year>2010</year>;<volume>201</volume>(<issue>5</issue>):<fpage>746</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1086/650530</pub-id>
<?supplied-pmid 20102270?><pub-id pub-id-type="pmid">20102270</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Wilder-Smith</surname><given-names>A</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>, <name><surname>Weaver</surname><given-names>SC</given-names></name>, <name><surname>Monath</surname><given-names>TP</given-names></name>, <name><surname>Heymann</surname><given-names>DL</given-names></name>, <name><surname>Scott</surname><given-names>TW</given-names></name>. <article-title>Epidemic arboviral diseases: priorities for research and public health</article-title>. <source>Lancet Infect Dis</source>. <year>2017</year>;<volume>17</volume>(<issue>3</issue>):<fpage>e101</fpage>&#x02013;<lpage>e6</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(16)30518-7</pub-id>
<?supplied-pmid 28011234?><pub-id pub-id-type="pmid">28011234</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>H</given-names></name>, <name><surname>Hammack</surname><given-names>C</given-names></name>, <name><surname>Ogden</surname><given-names>SC</given-names></name>, <name><surname>Wen</surname><given-names>Z</given-names></name>, <name><surname>Qian</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth</article-title>. <source>Cell Stem Cell</source>. <year>2016</year>;<volume>18</volume>(<issue>5</issue>):<fpage>587</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2016.02.016</pub-id>
<?supplied-pmid 26952870?><pub-id pub-id-type="pmid">26952870</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Mehta</surname><given-names>R</given-names></name>, <name><surname>Soares</surname><given-names>CN</given-names></name>, <name><surname>Medialdea-Carrera</surname><given-names>R</given-names></name>, <name><surname>Ellul</surname><given-names>M</given-names></name>, <name><surname>da Silva</surname><given-names>MTT</given-names></name>, <name><surname>Rosala-Hallas</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2018</year>;<volume>12</volume>(<issue>2</issue>):<fpage>e0006212</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0006212</pub-id>
<?supplied-pmid 29432457?><pub-id pub-id-type="pmid">29432457</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Wilder-Smith</surname><given-names>A</given-names></name>, <name><surname>Preet</surname><given-names>R</given-names></name>, <name><surname>Renhorn</surname><given-names>KE</given-names></name>, <name><surname>Ximenes</surname><given-names>RA</given-names></name>, <name><surname>Rodrigues</surname><given-names>LC</given-names></name>, <name><surname>Solomon</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>ZikaPLAN: Zika Preparedness Latin American Network</article-title>. <source>Glob Health Action</source>. <year>2017</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1398485</fpage>
<pub-id pub-id-type="doi">10.1080/16549716.2017.1398485</pub-id>
<?supplied-pmid 29235414?><pub-id pub-id-type="pmid">29235414</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Cao-Lormeau</surname><given-names>VM</given-names></name>, <name><surname>Blake</surname><given-names>A</given-names></name>, <name><surname>Mons</surname><given-names>S</given-names></name>, <name><surname>Lastere</surname><given-names>S</given-names></name>, <name><surname>Roche</surname><given-names>C</given-names></name>, <name><surname>Vanhomwegen</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10027</issue>):<fpage>1531</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00562-6</pub-id>
<?supplied-pmid 26948433?><pub-id pub-id-type="pmid">26948433</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref024"><label>24</label><mixed-citation publication-type="journal"><collab>Pan American Health Organization</collab>. <source>Regional Zika Epidemiological Update (Americas)</source>
<month>8</month>
<volume>25</volume>, <fpage>2017</fpage> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=13622:25-august-2017-zika-epidemiological-update&#x00026;Itemid=42346&#x00026;lang=en">https://www.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=13622:25-august-2017-zika-epidemiological-update&#x00026;Itemid=42346&#x00026;lang=en</ext-link></mixed-citation></ref><ref id="pntd.0007622.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Dos Santos</surname><given-names>T</given-names></name>, <name><surname>Rodriguez</surname><given-names>A</given-names></name>, <name><surname>Almiron</surname><given-names>M</given-names></name>, <name><surname>Sanhueza</surname><given-names>A</given-names></name>, <name><surname>Ramon</surname><given-names>P</given-names></name>, <name><surname>De Oliveira</surname><given-names>WK</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus and the Guillain-Barre syndrome&#x02014;Case series from seven countries</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>375</volume>(<issue>16</issue>):<fpage>1598</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1609015</pub-id>
<?supplied-pmid 27579558?><pub-id pub-id-type="pmid">27579558</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Krauer</surname><given-names>F</given-names></name>, <name><surname>Riesen</surname><given-names>M</given-names></name>, <name><surname>Reveiz</surname><given-names>L</given-names></name>, <name><surname>Oladapo</surname><given-names>OT</given-names></name>, <name><surname>Mart&#x000ed;nez-Vega</surname><given-names>R</given-names></name>, <name><surname>Porgo</surname><given-names>TV</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barr&#x000e9; Syndrome: Systematic Review</article-title>. <source>PLoS Med</source>. <year>2017</year>;<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002203</pub-id>
<?supplied-pmid 28045901?><pub-id pub-id-type="pmid">28045901</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Balavoine</surname><given-names>S</given-names></name>, <name><surname>Pircher</surname><given-names>M</given-names></name>, <name><surname>Hoen</surname><given-names>B</given-names></name>, <name><surname>Herrmann-Storck</surname><given-names>C</given-names></name>, <name><surname>Najioullah</surname><given-names>F</given-names></name>, <name><surname>Madeux</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Guillain-Barre syndrome and chikungunya: description of all cases diagnosed during the 2014 outbreak in the French West Indies</article-title>. <source>Am J Trop Med Hyg</source>. <year>2017</year>;<volume>97</volume>(<issue>2</issue>):<fpage>356</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.15-0753</pub-id>
<?supplied-pmid 28722564?><pub-id pub-id-type="pmid">28722564</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Pinheiro</surname><given-names>TJ</given-names></name>, <name><surname>Guimaraes</surname><given-names>LF</given-names></name>, <name><surname>Silva</surname><given-names>MT</given-names></name>, <name><surname>Soares</surname><given-names>CN</given-names></name>. <article-title>Neurological manifestations of Chikungunya and Zika infections</article-title>. <source>Arq Neuropsiquiatr</source>. <year>2016</year>;<volume>74</volume>(<issue>11</issue>):<fpage>937</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1590/0004-282X20160138</pub-id>
<?supplied-pmid 27901259?><pub-id pub-id-type="pmid">27901259</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Carod-Artal</surname><given-names>FJ</given-names></name>, <name><surname>Wichmann</surname><given-names>O</given-names></name>, <name><surname>Farrar</surname><given-names>J</given-names></name>, <name><surname>Gascon</surname><given-names>J</given-names></name>. <article-title>Neurological complications of dengue virus infection</article-title>. <source>Lancet Neurol</source>. <year>2013</year>;<volume>12</volume>(<issue>9</issue>):<fpage>906</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(13)70150-9</pub-id>
<?supplied-pmid 23948177?><pub-id pub-id-type="pmid">23948177</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref030"><label>30</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <source>Assessment and management of Guillain-Barr&#x000e9; syndrome in the context of Zika virus infection</source>. <year>2016</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/resources/publications/zika/guillain-barre-syndrome/en/">https://www.who.int/csr/resources/publications/zika/guillain-barre-syndrome/en/</ext-link></mixed-citation></ref><ref id="pntd.0007622.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Shamseer</surname><given-names>L</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Clarke</surname><given-names>M</given-names></name>, <name><surname>Ghersi</surname><given-names>D</given-names></name>, <name><surname>Liberati</surname><given-names>A</given-names></name>, <name><surname>Petticrew</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation</article-title>. <source>BMJ</source>. <year>2015</year>;<volume>350</volume>:<fpage>g7647</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.g7647</pub-id>
<?supplied-pmid 25555855?><pub-id pub-id-type="pmid">25555855</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Hoy</surname><given-names>D</given-names></name>, <name><surname>Brooks</surname><given-names>P</given-names></name>, <name><surname>Woolf</surname><given-names>A</given-names></name>, <name><surname>Blyth</surname><given-names>F</given-names></name>, <name><surname>March</surname><given-names>L</given-names></name>, <name><surname>Bain</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement</article-title>. <source>J Clin Epidemiol</source>. <year>2012</year>;<volume>65</volume>(<issue>9</issue>):<fpage>934</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jclinepi.2011.11.014</pub-id>
<?supplied-pmid 22742910?><pub-id pub-id-type="pmid">22742910</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref033"><label>33</label><mixed-citation publication-type="book"><collab>Institute of Medicine Committee to Review the Adverse Consequences of P</collab>, <name><surname>Rubella</surname><given-names>V</given-names></name>. <chapter-title>The National Academies Collection: Reports funded by National Institutes of Health</chapter-title> In: <name><surname>Howson</surname><given-names>CP</given-names></name>, <name><surname>Howe</surname><given-names>CJ</given-names></name>, <name><surname>Fineberg</surname><given-names>HV</given-names></name>, editors. <source>Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>, <year>1991</year>.</mixed-citation></ref><ref id="pntd.0007622.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Barendregt</surname><given-names>JJ</given-names></name>, <name><surname>Doi</surname><given-names>SA</given-names></name>, <name><surname>Lee</surname><given-names>YY</given-names></name>, <name><surname>Norman</surname><given-names>RE</given-names></name>, <name><surname>Vos</surname><given-names>T</given-names></name>. <article-title>Meta-analysis of prevalence</article-title>. <source>J Epidemiol Community Health</source>. <year>2013</year>;<volume>67</volume>(<issue>11</issue>):<fpage>974</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/jech-2013-203104</pub-id>
<?supplied-pmid 23963506?><pub-id pub-id-type="pmid">23963506</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Olive</surname><given-names>JM</given-names></name>, <name><surname>Castillo</surname><given-names>C</given-names></name>, <name><surname>Castro</surname><given-names>RG</given-names></name>, <article-title>Quadros CAd. Epidemiologic study of Guillain-Barre syndrome in children &#x0003c;15 years of age in Latin America</article-title>. <source>J Infect Dis</source>. <year>1997</year>;<volume>175</volume>(<issue>Suppl. 1</issue>):<fpage>S160</fpage>&#x02013;<lpage>S4</lpage>.<pub-id pub-id-type="pmid">9203710</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Silveira</surname><given-names>CMd</given-names></name>, <name><surname>Salisbury</surname><given-names>DM</given-names></name>, <name><surname>Quadros</surname><given-names>CAd</given-names></name>. <article-title>Measles vaccination and Guillain-Barre syndrome</article-title>. <source>Lancet</source>. <year>1997</year>;<volume>349</volume>(<issue>9044</issue>):<fpage>14</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(96)07408-9</pub-id>
<?supplied-pmid 8988116?><pub-id pub-id-type="pmid">8988116</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Molinero</surname><given-names>MR</given-names></name>, <name><surname>Varon</surname><given-names>D</given-names></name>, <name><surname>Holden</surname><given-names>KR</given-names></name>, <name><surname>Sladky</surname><given-names>JT</given-names></name>, <name><surname>Molina</surname><given-names>IB</given-names></name>, <name><surname>Cleaves</surname><given-names>F</given-names></name>. <article-title>Epidemiology of childhood Guillain-Barre syndrome as a cause of acute flaccid paralysis in Honduras: 1989&#x02013;1999</article-title>. <source>J Child Neurol</source>. <year>2003</year>;<volume>18</volume>(<issue>11</issue>):<fpage>741</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1177/08830738030180110801</pub-id>
<?supplied-pmid 14696900?><pub-id pub-id-type="pmid">14696900</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>De la Pena</surname><given-names>O</given-names></name>, <name><surname>Robles-Figueroa</surname><given-names>M</given-names></name>, <name><surname>Chavez-Pena</surname><given-names>Q</given-names></name>, <name><surname>Bedolla-Barajas</surname><given-names>M</given-names></name>. [<article-title>Features of Guillain-Barre syndrome in adults: results of a university hospital</article-title>]. <source>Rev Med Inst Mex Seguro Soc</source>. <year>2015</year>;<volume>53</volume>(<issue>6</issue>):<fpage>678</fpage>&#x02013;<lpage>85</lpage>. <?supplied-pmid 26506483?><pub-id pub-id-type="pmid">26506483</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Rojas</surname><given-names>JI</given-names></name>, <name><surname>Giunta</surname><given-names>D</given-names></name>, <name><surname>Patrucco</surname><given-names>L</given-names></name>, <name><surname>Stefani</surname><given-names>C</given-names></name>, <name><surname>Rosso</surname><given-names>B</given-names></name>, <name><surname>Rugiero</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Incidence of Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome in Argentina</article-title>. <source>Neurology</source>. <year>2009</year>;<volume>72</volume>(<issue>11</issue>):<fpage>A451</fpage>&#x02013;<lpage>A</lpage>.</mixed-citation></ref><ref id="pntd.0007622.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Codeb&#x000f3;</surname><given-names>O</given-names></name>, <name><surname>Bonanno</surname><given-names>D</given-names></name>, <name><surname>Almeida</surname><given-names>V</given-names></name>, <name><surname>Dorigo</surname><given-names>A</given-names></name>, <name><surname>Gazia</surname><given-names>V</given-names></name>, <name><surname>Poyard</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Guillain-Barr&#x000e9; Syndrome in Argentina: Its Public Health Relevance in Light of Zika Virus Emergence</article-title>. <source>Revista Argentina de Salud P&#x000fa;blica</source>. <year>2016</year>;<volume>7</volume>(<issue>28</issue>):<fpage>38</fpage>&#x02013;<lpage>40</lpage>.</mixed-citation></ref><ref id="pntd.0007622.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Dias-Tosta</surname><given-names>E</given-names></name>, <name><surname>Kuckelhaus</surname><given-names>CS</given-names></name>. <article-title>Guillain Barre syndrome in a population less than 15 years old in Brazil</article-title>. <source>Arq Neuropsiquiatr</source>. <year>2002</year>;<volume>60</volume>(<issue>2 B</issue>):<fpage>367</fpage>&#x02013;<lpage>73</lpage>. <?supplied-pmid 12131933?><pub-id pub-id-type="pmid">12131933</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Dourado</surname><given-names>ME</given-names></name>, <name><surname>Felix</surname><given-names>RH</given-names></name>, <name><surname>Silva</surname><given-names>WKAd</given-names></name>, <name><surname>Queiroz</surname><given-names>JW</given-names></name>, <name><surname>Jeronimo</surname><given-names>SMB</given-names></name>. <article-title>Clinical characteristics of Guillain-Barre syndrome in a tropical country: a Brazilian experience</article-title>. <source>Acta Neurol Scand</source>. <year>2012</year>;<volume>125</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0404.2011.01503.x</pub-id>
<?supplied-pmid 21428966?><pub-id pub-id-type="pmid">21428966</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Guimaraes Rocha</surname><given-names>MS</given-names></name>, <name><surname>Dozzi Brucki</surname><given-names>SM</given-names></name>, <name><surname>De Siqueira Carvalho</surname><given-names>AA</given-names></name>, <name><surname>Poti Lima</surname><given-names>UW</given-names></name>. <article-title>Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil</article-title>. <source>Arq Neuropsiquiatr</source>. <year>2004</year>;<volume>62</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1590/s0004-282x2004000100006</pub-id>
<?supplied-pmid 15122430?><pub-id pub-id-type="pmid">15122430</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Rivera-Lillo</surname><given-names>G</given-names></name>, <name><surname>Torres-Castro</surname><given-names>R</given-names></name>, <name><surname>Burgos</surname><given-names>PI</given-names></name>, <name><surname>Varas-Diaz</surname><given-names>G</given-names></name>, <name><surname>Vera-Uribe</surname><given-names>R</given-names></name>, <name><surname>Puppo</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Incidence of Guillain-Barre syndrome in Chile: a population-based study</article-title>. <source>J Peripher Nerv Syst</source>. <year>2016</year>;<volume>21</volume>(<issue>4</issue>):<fpage>339</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1111/jns.12182</pub-id>
<?supplied-pmid 27477441?><pub-id pub-id-type="pmid">27477441</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Hart</surname><given-names>DE</given-names></name>, <name><surname>Rojas</surname><given-names>LA</given-names></name>, <name><surname>Rosario</surname><given-names>JA</given-names></name>, <name><surname>Recalde</surname><given-names>H</given-names></name>, <name><surname>Roman</surname><given-names>GC</given-names></name>. <article-title>Childhood Guillain-Barre syndrome in Paraguay, 1990 to 1991</article-title>. <source>Ann Neurol</source>. <year>1994</year>;<volume>36</volume>(<issue>6</issue>):<fpage>859</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410360609</pub-id>
<?supplied-pmid 7998771?><pub-id pub-id-type="pmid">7998771</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Suryapranata</surname><given-names>FS</given-names></name>, <name><surname>Ang</surname><given-names>CW</given-names></name>, <name><surname>Chong</surname><given-names>LL</given-names></name>, <name><surname>Murk</surname><given-names>JL</given-names></name>, <name><surname>Falconi</surname><given-names>J</given-names></name>, <name><surname>Huits</surname><given-names>RM</given-names></name>. <article-title>Epidemiology of Guillain-Barre Syndrome in Aruba</article-title>. <source>Am J Trop Med Hyg</source>. <year>2016</year>;<volume>94</volume>(<issue>6</issue>):<fpage>1380</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.15-0070</pub-id>
<?supplied-pmid 27022152?><pub-id pub-id-type="pmid">27022152</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>van Koningsveld</surname><given-names>R</given-names></name>, <name><surname>Rico</surname><given-names>R</given-names></name>, <name><surname>Gerstenbluth</surname><given-names>I</given-names></name>, <name><surname>Schmitz</surname><given-names>PI</given-names></name>, <name><surname>Ang</surname><given-names>CW</given-names></name>, <name><surname>Merkies</surname><given-names>IS</given-names></name>, <etal>et al</etal>
<article-title>Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean island Curacao</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>56</volume>(<issue>11</issue>):<fpage>1467</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.56.11.1467</pub-id>
<?supplied-pmid 11402102?><pub-id pub-id-type="pmid">11402102</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Salinas</surname><given-names>JL</given-names></name>, <name><surname>Major</surname><given-names>CG</given-names></name>, <name><surname>Pastula</surname><given-names>DM</given-names></name>, <name><surname>Dirlikov</surname><given-names>E</given-names></name>, <name><surname>Styczynski</surname><given-names>A</given-names></name>, <name><surname>Luciano</surname><given-names>CA</given-names></name>, <etal>et al</etal>
<article-title>Incidence and clinical characteristics of Guillain-Barre syndrome before the introduction of Zika virus in Puerto Rico</article-title>. <source>J Neurol Sci</source>. <year>2017</year>;<volume>377</volume>:<fpage>102</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2017.04.006</pub-id>
<?supplied-pmid 28477675?><pub-id pub-id-type="pmid">28477675</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>del Carpio-Orantes</surname><given-names>L</given-names></name>, <name><surname>Peniche Moguel</surname><given-names>KG</given-names></name>, <name><surname>S&#x000e1;nchez D&#x000ed;az</surname><given-names>JS</given-names></name>, <name><surname>Pola-Ramirez</surname><given-names>MR</given-names></name>, <name><surname>Mata Miranda</surname><given-names>MP</given-names></name>, <name><surname>Garc&#x000ed;a-M&#x000e9;ndez</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>S&#x000ed;ndrome de Guillain Barr&#x000e9; asociado a Zika, an&#x000e1;lisis de la cohorte delegacional en la regi&#x000f3;n Veracruz norte durante 2016&#x02013;2017</article-title>. <source>Neurologia</source>. <year>2018</year>
<pub-id pub-id-type="doi">10.33588/rn.6711.2018380</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Souza</surname><given-names>CO</given-names></name>, <name><surname>Vieira</surname><given-names>MACS</given-names></name>, <name><surname>Batista</surname><given-names>FMA</given-names></name>, <name><surname>Eulalio</surname><given-names>KD</given-names></name>, <name><surname>Neves</surname><given-names>JMM</given-names></name>, <name><surname>Sa</surname><given-names>LC</given-names></name>, <etal>et al</etal>
<article-title>Serological Markers of Recent Campylobacter jejuni Infection in Patients with Guillain-Barre Syndrome in the State of Piaui, Brazil, 2014&#x02013;2016</article-title>. <source>Am J Trop Med Hyg</source>. <year>2018</year>
<pub-id pub-id-type="doi">10.4269/ajtmh.17-0666</pub-id>
<?supplied-pmid 29313470?><pub-id pub-id-type="pmid">29313470</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Paploski</surname><given-names>IAD</given-names></name>, <name><surname>Prates</surname><given-names>APPB</given-names></name>, <name><surname>Cardoso</surname><given-names>CW</given-names></name>, <name><surname>Kikuti</surname><given-names>M</given-names></name>, <name><surname>Silva</surname><given-names>MMO</given-names></name>, <name><surname>Waller</surname><given-names>LA</given-names></name>, <etal>et al</etal>
<article-title>Time Lags between Exanthematous Illness Attributed to Zika Virus, Guillain-Barr&#x000e9; Syndrome, and Microcephaly, Salvador, Brazil</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>8</issue>):<fpage>1438</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3201/eid2208.160496</pub-id>
<?supplied-pmid 27144515?><pub-id pub-id-type="pmid">27144515</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Nobrega</surname><given-names>M</given-names></name>, <name><surname>Araujo</surname><given-names>ELL</given-names></name>, <name><surname>Wada</surname><given-names>MY</given-names></name>, <name><surname>Leite</surname><given-names>PLE</given-names></name>, <name><surname>Dimech</surname><given-names>GS</given-names></name>, <name><surname>Percio</surname><given-names>J</given-names></name>. <article-title>Outbreak of Guillain-Barre syndrome possibly related to prior Zika virus infection, Metropolitan Region of Recife, Pernambuco, Brazil, 2015</article-title>. <source>Epidemiologia e servicos de saude: revista do Sistema Unico de Saude do Brasil</source>. <year>2018</year>;<volume>27</volume>(<issue>2</issue>):<fpage>e2017039</fpage>
<pub-id pub-id-type="doi">10.5123/S1679-49742018000200016</pub-id>
<?supplied-pmid 29995102?><pub-id pub-id-type="pmid">29995102</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Styczynski</surname><given-names>AR</given-names></name>, <name><surname>Malta</surname><given-names>JM</given-names></name>, <name><surname>Krow-Lucal</surname><given-names>ER</given-names></name>, <name><surname>Percio</surname><given-names>J</given-names></name>, <name><surname>Nobrega</surname><given-names>ME</given-names></name>, <name><surname>Vargas</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Increased rates of Guillain-Barre syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2017</year>;<volume>11</volume>(<issue>8</issue>):<fpage>e0005869</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0005869</pub-id>
<?supplied-pmid 28854206?><pub-id pub-id-type="pmid">28854206</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref054"><label>54</label><mixed-citation publication-type="other">Piau&#x000ed;. Secretaria de Estado da Sa&#x000fa;de. [Arboviruses and neurological syndromes in Piau&#x000ed;] Bol Epidemiol Semanal. 2016 Nov 12; ed esp. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.saude.pi.gov.br/uploads/document/file/129/Boletim_agravos_neurol_gicos_nov_2016_WORD__2_.pdf">http://www.saude.pi.gov.br/uploads/document/file/129/Boletim_agravos_neurol_gicos_nov_2016_WORD__2_.pdf</ext-link></mixed-citation></ref><ref id="pntd.0007622.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Anaya</surname><given-names>JM</given-names></name>, <name><surname>Rodriguez</surname><given-names>Y</given-names></name>, <name><surname>Monsalve</surname><given-names>DM</given-names></name>, <name><surname>Vega</surname><given-names>D</given-names></name>, <name><surname>Ojeda</surname><given-names>E</given-names></name>, <name><surname>Gonzalez-Bravo</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cucuta</article-title>, <source>Colombia. J Autoimmun</source>. <year>2017</year>;<volume>77</volume>:<fpage>123</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2016.12.007</pub-id>
<?supplied-pmid 28062188?><pub-id pub-id-type="pmid">28062188</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Tolosa</surname><given-names>N</given-names></name>, <name><surname>Tinker</surname><given-names>SC</given-names></name>, <name><surname>Pacheco</surname><given-names>O</given-names></name>, <name><surname>Valencia</surname><given-names>D</given-names></name>, <name><surname>Botero</surname><given-names>DS</given-names></name>, <name><surname>Tong</surname><given-names>VT</given-names></name>, <etal>et al</etal>
<article-title>Zika Virus Disease in Children in Colombia, August 2015 to May 2016</article-title>. <source>Paediatr Perinat Epidemiol</source>. <year>2017</year>;<volume>31</volume>(<issue>6</issue>):<fpage>537</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/ppe.12391</pub-id>
<?supplied-pmid 28806479?><pub-id pub-id-type="pmid">28806479</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref057"><label>57</label><mixed-citation publication-type="book"><collab>Instituto Nacional de Salud</collab>. <source>Bolet&#x000ed;n Epidemiol&#x000f3;gico Semanal. Direcci&#x000f3;n de Vigilancia y An&#x000e1;lisis del Riesgo en Salud P&#x000fa;blica</source>. <publisher-loc>Bogot&#x000e1;, Colombia</publisher-loc>: <publisher-name>Instituto Nacional de Salud</publisher-name>; <year>2016</year>.</mixed-citation></ref><ref id="pntd.0007622.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Salinas</surname><given-names>JL</given-names></name>, <name><surname>Walteros</surname><given-names>DM</given-names></name>, <name><surname>Styczynski</surname><given-names>A</given-names></name>, <name><surname>Garzon</surname><given-names>F</given-names></name>, <name><surname>Quijada</surname><given-names>H</given-names></name>, <name><surname>Bravo</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Zika virus disease-associated Guillain-Barre syndrome-Barranquilla, Colombia 2015&#x02013;2016</article-title>. <source>J Neurol Sci</source>. <year>2017</year>;<volume>381</volume>:<fpage>272</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2017.09.001</pub-id>
<?supplied-pmid 28991697?><pub-id pub-id-type="pmid">28991697</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref059"><label>59</label><mixed-citation publication-type="other">N&#x000fa;n&#x000f1;ez R, Cornelio Y, Pimentel R. S&#x000ed;ndrome de Guillain Barr&#x000e9; asociado a Zika-Rep&#x000fa;blica Dominicana enero-octubre 2016. 9th TEPHINET Global Scientific Conference; Chiang Mai, Thailand 2017.</mixed-citation></ref><ref id="pntd.0007622.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Barcellos</surname><given-names>C</given-names></name>, <name><surname>Xavier</surname><given-names>DR</given-names></name>, <name><surname>Pavao</surname><given-names>AL</given-names></name>, <name><surname>Boccolini</surname><given-names>CS</given-names></name>, <name><surname>Pina</surname><given-names>MF</given-names></name>, <name><surname>Pedroso</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Increased Hospitalizations for Neuropathies as Indicators of Zika Virus Infection, according to Health Information System Data, Brazil</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1894</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid2211.160901</pub-id>
<?supplied-pmid 27603576?><pub-id pub-id-type="pmid">27603576</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Machado-Alba</surname><given-names>JE</given-names></name>, <name><surname>Machado-Duque</surname><given-names>ME</given-names></name>, <name><surname>Gaviria-Mendoza</surname><given-names>A</given-names></name>, <name><surname>Orozco-Giraldo</surname><given-names>V</given-names></name>. <article-title>Diagnosis of neurological disorders and the Zika virus epidemic</article-title> in <source>Colombia 2014&#x02013;2016. Int J Infect Dis</source>. <year>2016</year>;<volume>51</volume>:<fpage>133</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2016.09.010</pub-id>
<?supplied-pmid 27637419?><pub-id pub-id-type="pmid">27637419</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Roze</surname><given-names>B</given-names></name>, <name><surname>Najioullah</surname><given-names>F</given-names></name>, <name><surname>Ferge</surname><given-names>JL</given-names></name>, <name><surname>Dorleans</surname><given-names>F</given-names></name>, <name><surname>Apetse</surname><given-names>K</given-names></name>, <name><surname>Barnay</surname><given-names>JL</given-names></name>, <etal>et al</etal>
<article-title>Guillain-Barre Syndrome Associated with Zika Virus Infection in Martinique in 2016: A Prospective Study</article-title>. <source>Clin Infect Dis</source>. <year>2017</year>;<volume>65</volume>(<issue>9</issue>):<fpage>1462</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cix588</pub-id>
<?supplied-pmid 29020245?><pub-id pub-id-type="pmid">29020245</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Dirlikov</surname><given-names>E</given-names></name>, <name><surname>Major</surname><given-names>CG</given-names></name>, <name><surname>Medina</surname><given-names>NA</given-names></name>, <name><surname>Lugo-Robles</surname><given-names>R</given-names></name>, <name><surname>Matos</surname><given-names>D</given-names></name>, <name><surname>Munoz-Jordan</surname><given-names>JL</given-names></name>, <etal>et al</etal>
<article-title>Clinical Features of Guillain-Barre Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016</article-title>. <source>JAMA Neurol</source>. <year>2018</year>;<volume>75</volume>(<issue>9</issue>):<fpage>1089</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2018.1058</pub-id>
<?supplied-pmid 29799940?><pub-id pub-id-type="pmid">29799940</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Santos</surname><given-names>J</given-names></name>, <name><surname>Marques</surname><given-names>W</given-names></name>, <name><surname>Fazan</surname><given-names>VPS</given-names></name>, <name><surname>Barreira</surname><given-names>AA</given-names></name>. <article-title>No association between guillain-barre syndrome and dengue fever</article-title>. <source>J Peripher Nerv Syst</source>. <year>2009</year>;(<issue>2</issue>):<fpage>132</fpage>.</mixed-citation></ref><ref id="pntd.0007622.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>NM</given-names></name>, <name><surname>Cucunuba</surname><given-names>ZM</given-names></name>, <name><surname>Dorigatti</surname><given-names>I</given-names></name>, <name><surname>Nedjati-Gilani</surname><given-names>GL</given-names></name>, <name><surname>Donnelly</surname><given-names>CA</given-names></name>, <name><surname>Basanez</surname><given-names>MG</given-names></name>, <etal>et al</etal>
<article-title>Epidemiology. Countering the Zika epidemic in Latin America</article-title>. <source>Science</source>. <year>2016</year>;<volume>353</volume>(<issue>6297</issue>):<fpage>353</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.aag0219</pub-id>
<?supplied-pmid 27417493?><pub-id pub-id-type="pmid">27417493</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>O'Reilly</surname><given-names>KM</given-names></name>, <name><surname>Lowe</surname><given-names>R</given-names></name>, <name><surname>Edmunds</surname><given-names>WJ</given-names></name>, <name><surname>Mayaud</surname><given-names>P</given-names></name>, <name><surname>Kucharski</surname><given-names>A</given-names></name>, <name><surname>Eggo</surname><given-names>RM</given-names></name>, <etal>et al</etal>
<article-title>Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis</article-title>. <source>BMC Med</source>. <year>2018</year>;<volume>16</volume>(<issue>1</issue>):<fpage>180</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-018-1158-8</pub-id>
<?supplied-pmid 30285863?><pub-id pub-id-type="pmid">30285863</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Vellozzi</surname><given-names>C</given-names></name>, <name><surname>Iqbal</surname><given-names>S</given-names></name>, <name><surname>Broder</surname><given-names>K</given-names></name>. <article-title>Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence</article-title>. <source>Clin Infect Dis</source>. <year>2014</year>;<volume>58</volume>(<issue>8</issue>):<fpage>1149</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciu005</pub-id>
<?supplied-pmid 24415636?><pub-id pub-id-type="pmid">24415636</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Pearce</surname><given-names>JC</given-names></name>, <name><surname>Learoyd</surname><given-names>TP</given-names></name>, <name><surname>Langendorf</surname><given-names>BJ</given-names></name>, <name><surname>Logan</surname><given-names>JG</given-names></name>. <article-title>Japanese encephalitis: the vectors, ecology and potential for expansion</article-title>. <source>J Travel Med</source>. <year>2018</year>;<volume>25</volume>(<issue>suppl_1</issue>):<fpage>S16</fpage>&#x02013;<lpage>S26</lpage>. <pub-id pub-id-type="doi">10.1093/jtm/tay009</pub-id>
<?supplied-pmid 29718435?><pub-id pub-id-type="pmid">29718435</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Lindquist</surname><given-names>L</given-names></name>. <article-title>Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travellers</article-title>. <source>J Travel Med</source>. <year>2018</year>;<volume>25</volume>(<issue>suppl_1</issue>):<fpage>S3</fpage>&#x02013;<lpage>S9</lpage>. <pub-id pub-id-type="doi">10.1093/jtm/tay006</pub-id>
<?supplied-pmid 29718434?><pub-id pub-id-type="pmid">29718434</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Rezza</surname><given-names>G.</given-names></name>
<article-title>Chikungunya is back in Italy: 2007&#x02013;2017</article-title>. <source>J Travel Med</source>. <year>2018</year>;<volume>25</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1093/jtm/tay004</pub-id>
<?supplied-pmid 29669058?><pub-id pub-id-type="pmid">29669058</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Nakayama</surname><given-names>E</given-names></name>, <name><surname>Tajima</surname><given-names>S</given-names></name>, <name><surname>Kotaki</surname><given-names>A</given-names></name>, <name><surname>Shibasaki</surname><given-names>KI</given-names></name>, <name><surname>Itokawa</surname><given-names>K</given-names></name>, <name><surname>Kato</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>A summary of the imported cases of Chikungunya fever in Japan from 2006 to June 2016</article-title>. <source>J Travel Med</source>. <year>2018</year>;<volume>25</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1093/jtm/tax072</pub-id>
<?supplied-pmid 29394382?><pub-id pub-id-type="pmid">29394382</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Masyeni</surname><given-names>S</given-names></name>, <name><surname>Yohan</surname><given-names>B</given-names></name>, <name><surname>Somia</surname><given-names>IKA</given-names></name>, <name><surname>Myint</surname><given-names>KSA</given-names></name>, <name><surname>Sasmono</surname><given-names>RT</given-names></name>. <article-title>Dengue infection in international travellers visiting Bali, Indonesia</article-title>. <source>J Travel Med</source>. <year>2018</year>;<fpage>25</fpage>(1). <pub-id pub-id-type="doi">10.1093/jtm/tay061</pub-id>
<?supplied-pmid 30113689?><pub-id pub-id-type="pmid">30113689</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Riddell</surname><given-names>A</given-names></name>, <name><surname>Babiker</surname><given-names>ZO</given-names></name>. <article-title>Imported dengue fever in East London: a 6-year retrospective observational study</article-title>. <source>J Travel Med</source>. <year>2017</year>;<volume>24</volume>(<issue>3</issue>). <pub-id pub-id-type="doi">10.1093/jtm/tax015</pub-id>
<?supplied-pmid 28355620?><pub-id pub-id-type="pmid">28355620</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Jentes</surname><given-names>ES</given-names></name>, <name><surname>Lash</surname><given-names>RR</given-names></name>, <name><surname>Johansson</surname><given-names>MA</given-names></name>, <name><surname>Sharp</surname><given-names>TM</given-names></name>, <name><surname>Henry</surname><given-names>R</given-names></name>, <name><surname>Brady</surname><given-names>OJ</given-names></name>, <etal>et al</etal>
<article-title>Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians</article-title>. <source>J Travel Med</source>. <year>2016</year>;<volume>23</volume>(<issue>6</issue>). <pub-id pub-id-type="doi">10.1093/jtm/taw062</pub-id>
<?supplied-pmid 27625400?><pub-id pub-id-type="pmid">27625400</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>RW</given-names></name>, <name><surname>Henderson</surname><given-names>SJ</given-names></name>, <name><surname>Lee</surname><given-names>EA</given-names></name>, <name><surname>Jung</surname><given-names>P</given-names></name>. <article-title>Dengue in Peace Corps Volunteers, 2000&#x02013;14</article-title>. <source>J Travel Med</source>. <year>2016</year>;<volume>23</volume>(<issue>3</issue>). <pub-id pub-id-type="doi">10.1093/jtm/taw010</pub-id>
<?supplied-pmid 27356308?><pub-id pub-id-type="pmid">27356308</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Neuberger</surname><given-names>A</given-names></name>, <name><surname>Turgeman</surname><given-names>A</given-names></name>, <name><surname>Lustig</surname><given-names>Y</given-names></name>, <name><surname>Schwartz</surname><given-names>E</given-names></name>. <article-title>Dengue fever among Israeli expatriates in Delhi, 2015: implications for dengue incidence in Delhi, India</article-title>. <source>J Travel Med</source>. <year>2016</year>;<volume>23</volume>(<issue>3</issue>). <pub-id pub-id-type="doi">10.1093/jtm/taw003</pub-id>
<?supplied-pmid 26929156?><pub-id pub-id-type="pmid">26929156</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Bogliun</surname><given-names>G</given-names></name>, <name><surname>Beghi</surname><given-names>E</given-names></name>, <collab>Italian GBS Registry Study Group</collab>. <article-title>Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barr&#x000e8; syndrome</article-title>. <source>Neurol Sci</source>. <year>2002</year>;<volume>23</volume>(<issue>1</issue>):<fpage>113</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">12391495</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>CD</given-names></name>, <name><surname>Jones</surname><given-names>TF</given-names></name>. <article-title>Optimizing a hospital discharge database for passive surveillance of guillain-barre syndrome</article-title>. <source>Ann Neurol</source>. <year>2011</year>;(<issue>15</issue>):<fpage>S41</fpage>.</mixed-citation></ref><ref id="pntd.0007622.ref079"><label>79</label><mixed-citation publication-type="book"><name><surname>Carmo</surname><given-names>E</given-names></name>, <name><surname>Gemal</surname><given-names>A</given-names></name>, <name><surname>Oliveira</surname><given-names>S</given-names></name>. <chapter-title>Vigilancia en Salud en Suramerica: epidemiologica, sanitaria y ambiental</chapter-title>
<publisher-loc>Rio de Janeiro</publisher-loc>: <publisher-name>Instituto Suramericano de Gobierno en Salud and UNASUR</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="pntd.0007622.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Hamer</surname><given-names>DH</given-names></name>, <name><surname>Chen</surname><given-names>LH</given-names></name>. <article-title>Zika in Angola and India</article-title>. <source>J Travel Med</source>. <year>2019</year>
<pub-id pub-id-type="doi">10.1093/jtm/taz012</pub-id>
<?supplied-pmid 30753689?><pub-id pub-id-type="pmid">30753689</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Watts</surname><given-names>AG</given-names></name>, <name><surname>Huber</surname><given-names>C</given-names></name>, <name><surname>Bogoch</surname><given-names>II</given-names></name>, <name><surname>Brady</surname><given-names>OJ</given-names></name>, <name><surname>Kraemer</surname><given-names>MUG</given-names></name>, <name><surname>Khan</surname><given-names>K</given-names></name>. <article-title>Potential Zika virus spread within and beyond India</article-title>. <source>J Travel Med</source>. <year>2018</year>;<fpage>25</fpage>(1). <pub-id pub-id-type="doi">10.1093/jtm/tay132</pub-id>
<?supplied-pmid 30476232?><pub-id pub-id-type="pmid">30476232</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref082"><label>82</label><mixed-citation publication-type="journal"><name><surname>Leder</surname><given-names>K</given-names></name>, <name><surname>Grobusch</surname><given-names>MP</given-names></name>, <name><surname>Gautret</surname><given-names>P</given-names></name>, <name><surname>Chen</surname><given-names>LH</given-names></name>, <name><surname>Kuhn</surname><given-names>S</given-names></name>, <name><surname>Lim</surname><given-names>PL</given-names></name>, <etal>et al</etal>
<article-title>Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>10</issue>):<fpage>e0185689</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0185689</pub-id> .<?supplied-pmid 28973011?><pub-id pub-id-type="pmid">28973011</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref083"><label>83</label><mixed-citation publication-type="journal"><name><surname>Wilder-Smith</surname><given-names>A</given-names></name>, <name><surname>Chang</surname><given-names>CR</given-names></name>, <name><surname>Leong</surname><given-names>WY</given-names></name>. <article-title>Zika in travellers 1947&#x02013;2017: a systematic review</article-title>. <source>J Travel Med</source>. <year>2018</year>;<volume>25</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1093/jtm/tay044</pub-id>
<?supplied-pmid 30016469?><pub-id pub-id-type="pmid">30016469</pub-id></mixed-citation></ref><ref id="pntd.0007622.ref084"><label>84</label><mixed-citation publication-type="journal"><name><surname>Leonhard</surname><given-names>SE</given-names></name>, <name><surname>Lant</surname><given-names>S</given-names></name>, <name><surname>Jacobs</surname><given-names>BC</given-names></name>, <name><surname>Wilder-Smith</surname><given-names>A</given-names></name>, <name><surname>Ferreira</surname><given-names>MLB</given-names></name>, <name><surname>Solomon</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Zika virus infection in the returning traveller: what every neurologist should know</article-title>. <source>Pract Neurol</source>. <year>2018</year>;<volume>18</volume>(<issue>4</issue>):<fpage>271</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/practneurol-2017-001789</pub-id>
<?supplied-pmid 29618586?><pub-id pub-id-type="pmid">29618586</pub-id></mixed-citation></ref></ref-list></back></article>